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contains 681 independent in vivo studies on 634 individual 
chemicals representing a wide range of chemical classes. 
A description of all the ocular effects observed in vivo, i.e. 
degree of severity and persistence of corneal opacity (CO), 
iritis, and/or conjunctiva effects, was added for each indi-
vidual study in the database, and the studies were catego-
rised according to their UN GHS/EU CLP classification 
and the main effect driving the classification. An evalu-
ation of the various in vivo drivers of classification com-
piled in the database was performed to establish which of 
these are most important from a regulatory point of view. 
These analyses established that the most important driv-
ers for Cat 1 Classification are (1) CO mean ≥ 3 (days 
1–3) (severity) and (2) CO persistence on day 21 in the 
absence of severity, and those for Cat 2 classification are 
(3) CO mean ≥ 1 and (4) conjunctival redness mean ≥ 2. 
Moreover, it is shown that all classifiable effects (including 
Abstract  A thorough understanding of which of the 
effects assessed in the in vivo Draize eye test are respon-
sible for driving UN GHS/EU CLP classification is criti-
cal for an adequate selection of chemicals to be used in 
the development and/or evaluation of alternative methods/
strategies and for properly assessing their predictive capac-
ity and limitations. For this reason, Cosmetics Europe has 
compiled a database of Draize data (Draize eye test Ref-
erence Database, DRD) from external lists that were cre-
ated to support past validation activities. This database 
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persistence and CO = 4) should be present in ≥60 % of 
the animals to drive a classification. As a consequence, our 
analyses suggest the need for a critical revision of the UN 
GHS/EU CLP decision criteria for the Cat 1 classification 
of chemicals. Finally, a number of key criteria are identi-
fied that should be taken into consideration when selecting 
reference chemicals for the development, evaluation and/or 
validation of alternative methods and/or strategies for seri-
ous eye damage/eye irritation testing. Most important, the 
DRD is an invaluable tool for any future activity involving 
the selection of reference chemicals.
Keywords UN GHS/EU CLP · Drivers of classification · 
Eye irritation/serious damage to the eye · Draize eye test 
Reference Database · Validation of alternative methods · 
Chemicals selection
Abbreviations
BCOP  Bovine Corneal Opacity and Permeability
CAS RN  Chemical Abstracts Service Registry 
Number
Cat 1  UN GHS/EU CLP classification for 
chemicals causing irreversible effects on 
the eye/serious damage to the eye
Cat 2  UN GHS/EU CLP classification for 
chemicals causing reversible effects on 
the eye/eye irritation, sub-categorised in 
2A (irritant to eyes, eye effects are not 
fully reversible within 7 days of observa-
tion) and 2B (mildly irritant to eyes, eye 
effects fully reversible within 7 days of 
observation)
CC  Conjunctival chemosis
CO  Corneal opacity
Conj  CR and/or CC
CR  Conjunctival redness
CM  Cytosensor Microphysiometer
DRD  Draize eye test Reference Database
ECETOC  European Centre for Toxicology and 
Ecotoxicology of Chemicals
EIT  Eye Irritation Test
EU CLP  European Union Regulation on Clas-
sification, Labelling and Packaging of 
chemicals implementing UN GHS in the 
EU
EURL ECVAM  European Union Reference Laboratory 
for Alternatives to Animal Testing
EVEIT  Ex Vivo Eye Irritation Test
FL  Fluorescein Leakage
HET-CAM  Hen’s Egg Test-Chorioallantoic 
Membrane
HPLC/UPLC  High-Performance Liquid Chroma-
tography/Ultra-Performance Liquid 
Chromatography
ICCVAM  Interagency Coordinating Committee on 
the Validation of Alternative Methods
ICE  Isolated Chicken Eye
IR  Iritis
IRE  Isolated Rabbit Eye
LNS  Laboratoire National de la Santé
MMAS  Modified Maximum Average Score
MSDS  Material Safety Data Sheet
NCD  European New Chemicals Database
NICEATM  National Toxicology Program Intera-
gency Center for the Evaluation of Alter-
native Toxicological Methods
No Cat  Chemicals not classified for serious eye 
damage/eye irritation under UN GHS/
EU CLP
OECD  Organisation for Economic Co-operation 
and Development
pers  Persistence
PorCORA  Porcine Corneal Ocular Reversibility 
Assay
RCD  Reference Chemicals Database
RhCE  Reconstructed human Cornea-like 
Epithelium
SCNM  Study Criteria Not Met
STE  Short-Time Exposure
TG  Test Guideline
UN GHS  United Nations Globally Harmonized 
System of classification and Labelling of 
Chemicals
US EPA  United States Environmental Protection 
Agency
ZEBET  Zentralstelle zur Erfassung und Bewer-
tung von Ersatz- und Ergänzungsmeth-
oden zum Tierversuch (Centre for Docu-
mentation and Evaluation of Alternatives 
to Animal Experiments at the Federal 
Institute for Risk Assessment (BfR))
Introduction
Several prospective and retrospective validation stud-
ies/activities for in vitro test methods in the area of seri-
ous eye damage/eye irritation have taken place over the 
last 20 years. These activities have led to the adoption of 
several methods by the Organisation for Economic Co-
operation and Development (OECD) as partial replace-
ment alternatives to the regulatory in vivo Draize rabbit eye 
test, i.e. OECD Test Guideline (TG) 405 (OECD 2012a). 
Currently, four test methods are accepted by the OECD to 
classify chemicals as inducing serious eye damage accord-
ing to the United Nations Globally Harmonized System 
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of Classification and Labelling of Chemicals (UN GHS) 
(UN 2013) and the European Union Regulation on Classi-
fication, Labelling and Packaging of chemicals (EU CLP) 
implementing UN GHS in EU (EC 2008) (UN GHS/EU 
CLP Category 1, herein after referred to as Cat 1). These 
are two organotypic assays, the Bovine Corneal Opacity 
and Permeability (BCOP) test method (OECD TG 437) 
and the Isolated Chicken Eye (ICE) test method (OECD 
TG 438) (OECD 2013a, b), and two cell-based assays, the 
Fluorescein Leakage (FL) test method (OECD TG 460) 
(OECD 2012b) and more recently the short-time exposure 
(STE) test method (Takahashi et al. 2008, 2009; Sakaguchi 
et al. 2011) validated by the Japanese Center for the Vali-
dation of Alternative Methods (JaCVAM) (Kojima et al. 
2013) and adopted by the OECD in 2015 (OECD TG 491) 
(OECD 2015a). The BCOP, ICE and STE are also accepted 
by the OECD for identifying chemicals not requiring clas-
sification for serious eye damage/eye irritation (UN GHS/
EU CLP No Category; herein after referred to as No Cat) 
(OECD 2013a, b, 2015a). Furthermore, a new TG (OECD 
TG 492) was also adopted by the OECD in 2015 for iden-
tifying chemicals not requiring classification for serious 
eye damage/eye irritation (No Cat) (OECD 2015b). TG 
492 describes the Reconstructed human Cornea-like Epi-
thelium (RhCE) test method EpiOcular™ Eye Irritation 
Test (EIT) that was validated in a prospective study coordi-
nated by EURL ECVAM/Cosmetics Europe (Freeman et al. 
2010). Finally, the Cytosensor Microphysiometer (CM) test 
method (Hartung et al. 2010) has been endorsed as scien-
tifically valid for limited applicability domains (EURL 
ECVAM 2008b; ESAC 2009; ICCVAM 2010) and is cur-
rently in the process of review by the OECD for the identi-
fication of chemicals inducing serious eye damage (Cat 1) 
as well as chemicals not requiring classification for serious 
eye damage/eye irritation (No Cat).
Partial replacement of the in vivo Draize rabbit eye test 
has been achieved through application of the regulatory 
accepted in vitro test methods that are mentioned above. 
Several analyses have been conducted to understand the 
limitations of alternative methods for predicting in vivo 
serious eye damage/eye irritation (Scott et al. 2010) and 
to explain why full replacement has not yet been reached 
(Bruner et al. 1998; York and Steiling 1998; Balls et al. 
1999; Adriaens et al. 2014). These reviews identified key 
causes that are briefly discussed below. For instance, in 
validation studies/activities performed during the 1990s 
(Balls et al. 1999) the results of the in vitro methods were 
often correlated with the modified maximum average score 
(MMAS) of the Draize eye test. The MMAS is a sum 
score of weighted individual tissue scores which combines 
effects of the test chemical on the cornea, iris and conjunc-
tiva into one score occurring at 24 h or later after instil-
lation without taking into account the reversibility of the 
effects. In contrast, more recent retrospective validation 
activities (ICCVAM 2007, 2010; EURL ECVAM 2008a, 
b) have already used the UN GHS/EU CLP classifica-
tion for serious eye damage/eye irritation (UN 2013; EC 
2008). In addition, the Eye Irritation Reference Chemicals 
data bank published by the European Centre for Toxicol-
ogy and Ecotoxicology of Chemicals (Bagley et al. 1992; 
ECETOC 1992) was many times the main, if not the only, 
database used for selecting test chemicals for valida-
tion studies. At that time, this database contained only 55 
chemicals (72 in vivo studies in total), and it was therefore 
not a comprehensive representation of chemical classes. 
Since this version of the ECETOC database was a funda-
mental source of in vivo data used in validation studies 
conducted in the 1990s, e.g. EC/HO (Balls et al. 1995) and 
COLIPA, now called Cosmetics Europe (Brantom et al. 
1997), the scope of chemicals selection was, to a certain 
extent, limited. Subsequently, a second more comprehen-
sive version of the ECETOC data bank extended to 132 
chemicals (149 in vivo studies in total) was published in 
1998 (Bagley et al. 1999; ECETOC 1998). Furthermore, 
variability of the responses observed between rabbits 
from historical data normally used as the in vivo reference 
in validation studies (Scott et al. 2010) was identified as 
potentially influencing the outcome of validation activities 
and acceptance of in vitro test methods. The impact of the 
uncertainty of in vivo reference data on the evaluation/vali-
dation of alternative methods was already illustrated by the 
resampling analysis presented by Adriaens et al. (2014). 
This analysis showed that the Draize eye test is prone to 
high misclassification errors. Importantly, these misclassi-
fication errors are unidirectional towards lower classifica-
tions. This means that about 12 % of the chemicals clas-
sified as Cat 2 and at least 11 % of those classified as Cat 
1 could in fact be equally identified as No Cat and as Cat 
2, respectively, by the in vivo Draize eye test considering 
only its within-test variability. This demonstrates that the 
way the Draize eye test data are interpreted is very con-
servative and may over-predict the true irritation potential 
of chemicals. As such, this over-prediction of Cat 1 and 
Cat 2 chemicals in the in vivo Draize eye test needs to be 
taken into account for determining acceptance of in vitro 
test methods. Based on this, Adriaens and co-workers 
therefore suggested to reconsider the UN GHS/EU CLP 
decision criteria for classification. This is in terms of the 
biological relevance of persistence of low-level conjunc-
tival effects in driving Cat 1 classification in the absence 
of any other Cat 1 triggering effects and Cat 1 classifica-
tion driven by persistent effects or corneal opacity of grade 
4 in a single animal, whereas the majority of the animals 
recover completely by day 21.
It is of importance to note that although more recent 
validation studies/activities such as those mentioned in 
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the first paragraph have used the UN GHS/EU CLP clas-
sification for serious eye damage/eye irritation (UN 2013; 
EC 2008) to interpret the in vivo data, consideration of the 
ocular tissues effects that drive classification were not inte-
grated in most of them. More recently, a comprehensive 
in-depth analysis of historical in vivo rabbit eye data co-
sponsored by Cosmetics Europe and the European Com-
mission was performed. This provided more insight into 
which of the observed in vivo effects are important in driv-
ing the classification of chemicals for serious eye damage/
eye irritation (Adriaens et al. 2014) according to the UN 
GHS/EU CLP classification (UN 2013; EC 2008). The 
insights gained have identified that, in fact, the main rea-
son that partial replacement only has been achieved, can 
be attributed to not taking into account the impact of the 
individual in vivo tissue effects driving classification. In the 
Draize rabbit eye test, the hazard potential of a test chemi-
cal is determined based on its effect on corneal opacity 
(CO), iritis (IR), conjunctival redness (CR) and conjuncti-
val chemosis (CC) in combination with full reversibility or 
persistence of any effect on the 21st day after instillation. 
In order to achieve full replacement of the in vivo Draize 
eye test, it is clear that in vitro test methods, alone or in 
combination, need to address the main ocular tissue effects 
that drive classification. In this respect, a thorough under-
standing of what drives classification of chemicals in the 
in vivo rabbit Draize eye test is a critical and essential ele-
ment to consider in the development of alternative meth-
ods, evaluation of their predictive capacity and limitations 
and identification of the applicability of a specific assay. 
The BCOP and ICE, for example, were developed to detect 
immediate corneal effects, equivalent to the first three 
observation days in the Draize eye test. However, both test 
methods, using current protocols (OECD 2013a, b), lack 
the ability to consistently identify delayed in vivo effects or 
mild/moderate in vivo effects that persist until day 21. Two 
other organotypic test methods, the Ex Vivo Eye Irritation 
Test (EVEIT) using isolated rabbit corneas (Spöler et al. 
2007; Frentz et al. 2008) and the Porcine Corneal Ocular 
Reversibility Assay (PorCORA) using isolated porcine 
corneas (Piehl et al. 2010, 2011), have been developed to 
address reversibility/persistence of effects. Both test meth-
ods are intended to directly monitor recovery in exposed 
excised corneas kept in culture over several days following 
test item administration. However, neither test method has 
yet undergone formal validation.
To succeed in the future to fully replace the Draize rab-
bit eye test, a consistent approach is needed to identify 
chemicals covering the different drivers of classification 
(Barroso et al. 2013; Adriaens et al. 2014) for use in devel-
opment, evaluation and validation of in vitro test methods. 
For this purpose, Cosmetics Europe undertook to compile 
an extensive list of chemicals for which historical in vivo 
Draize eye test data obtained according to OECD TG 405 
(OECD 2012a) are available. These data were sourced 
from several external databases that had been compiled and 
were used to support past validation activities for in vitro 
test methods. The comprehensive database developed by 
Cosmetics Europe systematically covers all drivers of clas-
sification based on the observed tissue effects, relevant 
chemical classes and physical states. This means that it can 
be used to appropriately select chemicals for the develop-
ment and evaluation of in vitro test methods. This approach 
will facilitate an early and thorough assessment of the per-
formance of a new in vitro test method and will help bet-
ter identify its limitations and applicability within testing 
strategies such as those suggested by Scott et al. (2010). 
Another consequence of an appropriate selection of chemi-
cals is that future validation studies/activities may be per-
formed on a smaller and more focused dataset of chemicals 
covering all important drivers of classification.
Taken together, the key goals for compiling this list 
were: (1) to enable a comprehensive analysis and under-
standing regarding in vivo drivers of classification based 
on the Draize eye test, (2) to further evaluate the variability 
of the Draize eye test based on data obtained from repeat 
studies, (3) to make available an extensive list of chemicals 
with TG 405 in vivo data, beyond those generally used his-
torically, for further method development and validation 
and (4) to provide guidance for selecting reference chemi-
cals based on understanding ocular tissue effects that drive 
classification in the in vivo rabbit Draize eye test. Beyond 
this, based on the unprecedented in-depth analysis pre-
sented in this paper, a critical revision of the UN GHS/EU 
CLP decision criteria for classification is advocated.
Development of the Draize eye test Reference 
Database (DRD)
Data sources
The Draize eye test Reference Database (DRD) provided 
in Supplementary Material 1 was compiled using different 
sources of historical in vivo Draize eye test data which were 
created to support past validation activities. These data 
were produced according to OECD TG 405 (OECD 2012a) 
using proprietary and commercially available chemicals. 
The data sources used were (1) the Eye Irritation Refer-
ence Chemicals Data Bank developed by ECETOC (Bagley 
et al. 1992, 1999; ECETOC 1998); (2) a database devel-
oped by ZEBET (Spielmann et al. 1996); (3) the database 
from Laboratoire National de la Santé (LNS) (Gautheron 
et al. 1994); (4) the database developed by the National 
Toxicology Program Interagency Center for the Evalua-
tion of Alternative Toxicological Methods (NICEATM) to 
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support the retrospective evaluations of the Bovine Corneal 
Opacity and Permeability (BCOP) test method, the Isolated 
Chicken Eye (ICE) test method, the Isolated Rabbit eye 
(IRE) test method, and the Hen’s Egg Test-Chorioallantoic 
Membrane (HET-CAM) that were performed by the Intera-
gency Coordinating Committee on the Validation of Alter-
native Methods (ICCVAM) (ICCVAM 2007, 2010); (5) the 
database developed by EURL ECVAM to support the pro-
spective validation study of RhCE-based test methods per-
formed by EURL ECVAM and Cosmetics Europe; and (6) 
five studies that were not included in the other databases 
but that were used in the Cosmetics Europe study on the 
use of HPLC/UPLC spectrophotometry in Reconstructed 
human Tissue (RhT)-based test methods (Alépée et al. 
2015).
UN GHS classification
The studies on commercially and proprietary available 
chemicals collected in the DRD (Supplementary Mate-
rial 1) were classified according to the serious eye dam-
age/eye irritation classification criteria defined by UN 
GHS (UN 2013) and EU CLP (EC 2008), which imple-
mented UN GHS in the EU. These classification crite-
ria are derived from testing in albino rabbits according 
to the Draize eye test method (OECD 2012a) and are 
primarily based on the severity of effects and/or the tim-
ing of their reversibility. According to the UN GHS/EU 
CLP classification system, Category 1 (Cat 1) is defined 
as causing irreversible effects on the eye/serious damage 
to the eye and Category 2 (Cat 2) as causing reversible 
effects (fully reversible within 21 days) on the eye/eye 
irritation. UN GHS offers the possibility to further sub-
categorise Cat 2 into two optional categories, i.e. Cat-
egory 2A (Cat 2A) (irritant to eyes) when the eye effects 
are not fully reversible within 7 days of observation and 
Category 2B (Cat 2B) (mildly irritant to eyes) when 
the eye effects fully reverse within 7 days of observa-
tion. These two optional categories were not imple-
mented in EU CLP. If none of the criteria for Cat 1 and 
Cat 2 are met, the chemical does not require classifica-
tion for serious eye damage/eye irritation and therefore 
No Category (No Cat) is assigned. An overview of the 
UN GHS/EU CLP classification criteria is presented in 
Table 1. According to this classification system there are 
11 different criteria derived from the four tissue effects 
assessed in the Draize eye test, namely corneal opacity 
(CO), iritis (IR), conjunctival redness (CR) and con-
junctival chemosis (CC), which can each independently 
drive the classification of a chemical. These different 
criteria are here named as “drivers of classification” and 
they are: “CO mean ≥ 3” and “IR mean > 1.5” for Cat 
Table 1  Classification rules defined by UN GHS (UN 2013) and EU CLP (EC 2008)
Bold text indicates criteria for the different ocular tissues that drive classification
a Mean scores are calculated for each animal from gradings at 24, 48, and 72 h after instillation of the test chemical and these “severity scores” 
are then used to determine the classification of the test chemical
b Cat 1 also applies when other severe reactions (e.g. destruction of cornea, discoloration of the cornea by a dye substance, adhesion, pannus, 
or interference with the function of the iris or other effects that impair sight) are observed at any time point in any rabbit during the observation 
period
c All effects have to fully reverse within an observation period of normally 21 days. UN GHS provides the option to distinguish this single haz-
ard category into two optional subcategories (not implemented in EU CLP): “Category 2A” (irritant to eyes) when any of the eye effects in any 
animal is not fully reversible within 7 days of observation (i.e. CO, IR, CR and/or CC > 0 at 7 ≤ day < 21); “Category 2B” (mildly irritant to 
eyes) when all observed eye effects are fully reversible within 7 days of observation (i.e. CO, IR, CR and CC = 0 on day 7 and beyond)
Endpoint Range  
scoresa
Category 1b
Irreversible effects on the eye/serious eye damage
Category 2c
Reversible effects on the eye/eye irritation
Draize severity scoresa and/or persistence  
of effects on day 21
Draize severity scoresa
Corneal opacity (CO) 0–4 CO mean ≥ 3 (in ≥60 % of the tested animals),  
OR CO > 0 on day 21 in at least 1 animal  
(CO pers D21), OR CO = 4 at any time point  
in any animal, OR
CO mean ≥ 1 (in ≥60 % of the tested animals), 
OR
Iritis (IR) 0–2 IR mean > 1.5 (in ≥60 % of the tested animals), 
OR IR > 0 on day 21 in at least 1 animal  
(IR pers D21), OR
IR mean ≥ 1 (in ≥60 % of the tested animals), 
OR
Conjunctival redness (CR) 0–3 CR > 0 on day 21 in at least 1 animal  
(CR pers D21), OR
CR mean ≥ 2 (in ≥60 % of the tested animals), 
OR
Conjunctival chemosis (CC) 0–4 CC > 0 on day 21 in at least 1 animal  
(CC pers D21)
CC mean ≥ 2 (in ≥60 % of the tested animals)
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1 based on immediate severity appearing during the first 
three observation days in ≥60 % of the animals (i.e. in 
at least 2 out of 3, 3 out of 4, 3 out of 5 or 4 out of 
6); “CO pers D21”, “CR pers D21”, “CC pers D21” and 
“IR pers D21” for Cat 1 based on persistence (pers) of 
effects on day 21 (D21) observed in at least 1 animal; 
“CO = 4” for Cat 1 based on specific observations made 
in at least 1 animal; “CO mean ≥ 1”, “CR mean ≥ 2”, 
“CC mean ≥ 2” and “IR mean ≥ 1” for Cat 2 based on 
effects appearing during the first three observation days 
in ≥60 % of the animals (i.e. in at least 2 out of 3, 3 
out of 4, 3 out of 5 or 4 out of 6). In previous analyses 
it was shown that CC rarely drives the classification of 
chemicals on its own (about 2 % of the Cat 2 chemicals) 
(Adriaens et al. 2014; Barroso and Norman 2014) and 
can therefore be considered unimportant as a driver of 
classification. It was therefore decided not to report CR 
and CC separately in this study. CR and CC were thus 
independently assessed as defined in UN GHS/EU CLP 
but reported together as “Conj pers D21” for Cat 1, and 
“Conj mean ≥ 2” for Cat 2, leading to a total of nine dif-
ferent drivers of classification instead of the original 11 
criteria mentioned above (Tables 1, 2). 
Categorisation of the studies according to their main 
driver of classification
A chemical can be classified based on a single or multi-
ple drivers of classification. All drivers of classification 
observed in each study are reported in the DRD (Supple-
mentary Material 1). For the purpose of this publication, 
the Cat 1 and Cat 2 studies were grouped according to 
their main driver of classification (Table 2), which is shown 
in boldface within a greyed cell for every Cat 1 and Cat 
2 study reported in the DRD (Supplementary Material 1). 
The selection of the main driver of classification in each 
study was done according to the following prioritisation 
scheme. Chemicals classified as Cat 1 were first grouped 
based on (1) severity (mean scores of days 1–3); (2) per-
sistence of any ocular effect on day 21 in the absence of 
severity; or (3) CO = 4 (at any observation time during the 
study) in the absence of both severity and persistence (or if 
unknown). CO = 4 was given the lowest priority because, 
in many cases for ethical reasons, studies showing CO = 4 
were terminated before day 21, thereby having less com-
plete data and lacking information on the persistence/
reversibility of the effects. In some cases, information on 
severity was even not available because the study was ter-
minated before day 3. Next, for the severity and persistence 
groups, the endpoint (“CO”, “IR”, “Conj”) showing the 
largest number of animals fulfilling the classification cri-
terion was chosen as the main in vivo driver of classifica-
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criteria for different drivers, highest priority was given to 
CO, followed by Conj and finally IR when selecting the 
main driver of classification (Table 2). Chemicals classified 
as Cat 2 were allocated to one of three different groups, 
with the endpoint (“CO”, “Conj”, and “IR”) showing the 
largest number of animals fulfilling the classification crite-
rion being chosen as the main in vivo driver of classifica-
tion (Table 2). If equal number of animals fulfilled the clas-
sification criteria for different drivers, highest priority was 
again given to CO, followed by Conj and finally IR when 
selecting the main driver of classification (Table 2). For the 
Cat 2 chemicals, the persistence of effects on day 7 was 
also annotated to allow differentiation between Cat 2B and 
Cat 2A (Supplementary Material 1).
The prioritisation of the different endpoints within the 
severity and persistence groups, i.e. CO > Conj > IR, is 
based and builds on the analyses published by Adriaens 
et al. (2014). In that paper evidence was provided that CO 
is the most important endpoint driving the classification of 
Cat 1 chemicals and is almost as important as CR in driving 
the classification of Cat 2 chemicals (Adriaens et al. 2014; 
Barroso and Norman 2014). Considering that effects on 
the cornea can lead to visual impairment while conjuncti-
val effects are of lesser importance in this respect, CO was 
given the highest priority followed by conjunctival effects 
(CR/CC). Iritis was found to rarely drive the classification 
of chemicals (<4 % of both Cat 1 and Cat 2 chemicals) and 
is mostly accompanied by corneal effects generating the 
same classification (Supplementary Material 1). Iritis was 
therefore given the lowest priority.
Studies with chemicals not requiring classification for 
serious eye damage/eye irritation (No Cat) were distributed 
in four different groups depending on whether they showed 
CO scores equal to 0 in all animals and all observed time 
points (CO = 0) or not (CO > 0). Only CO was analysed 
for scores equal to or higher than 0, in line with it being 
defined as the endpoint with highest priority. Nevertheless, 
No Cat studies for which at least one animal had a mean 
of the scores of days 1–3 above the classification cut-off 
for at least one endpoint but not enough animals to gener-
ate a classification (borderline cases) were marked with 
**. For example, study No. 324 (N,N-Dimethyl guanidine 
sulphate) was assigned to the subgroup CO = 0** because 
the CO scores were equal to 0 in all animals and all time 
points, and because one out of three animals showed a 
mean of the CR scores of days 1–3 equal to or higher than 
2 (Supplementary Material 1). If any of the other two ani-
mals had also fulfilled this criterion (CR mean ≥ 2), the 
chemical would have been classified as Cat 2. Study No. 
275 (1,2,3-Trichloropropane) is an example of a chemical 
assigned to subgroup CO > 0 because all three tested ani-
mals showed a CO score > 1 at hour 1 and two of those ani-
mals also on day 1 (Supplementary Material 1). However, 
none of these animals showed a mean of the scores of days 
1–3 above the classification cut-off for any of the endpoints 
and therefore the ** do not apply.
Finally, for several studies the data available were not 
sufficient to allow a definitive and unambiguous classifi-
cation of the tested chemical due to one or several of the 
following reasons: (1) if the study was terminated before 
21 days without full reversibility (scores equal to 0) of 
all endpoints in all animals, in the absence of any other 
effects driving a Cat 1 classification, (2) if only two ani-
mals were used and no effects driving a Cat 1 classifica-
tion were observed, or (3) if only one animal was used and 
no CO = 4 and/or persistent effects were observed. These 
studies were identified as Study Criteria Not Met (SCNM). 
Where possible considering the available data, the most 
probable classification of the chemicals tested in these 
studies was indicated in brackets after SCNM (Supplemen-
tary Material 1).
Draize eye test Reference Database (DRD)
The DRD (Supplementary Material 1) contains 681 inde-
pendent Draize eye test studies, which are identified in the 
first three columns by a “Study Number” (ranging from 1 
to 681), “Test Chemical Name” and the Chemical Abstracts 
Service Registry Number (“CAS RN”) of the test chemi-
cal. Chemical classes were assigned to most of the chemi-
cals listed in the DRD according to OECD QSAR Toolbox 
analysis (version 3.2; http://www.oecd.org/chemicalsafety/
risk-assessment/theoecdqsartoolbox.htm). A profiler com-
prising around 430 nested categories was implemented 
which assigns effective organic class according to full func-
tional group, without subdivision of component fragments. 
For example, RCOOH would be classed as carboxylic acid 
only, without allocation of ketone and alcohol classes, 
respectively, to subsidiary CO and OH constituents. The 
chemical classes assigned to each chemical are listed in the 
column “Organic Functional Groups”. Additionally, three 
inorganic salts were identified.
The studies included in the DRD were first ordered by 
UN GHS classification starting with Cat 1 (No. 1–165), fol-
lowed by Cat 2A (No. 166–216), Cat 2 (No. 217), Cat 2B 
(No. 218–244), No Cat (No. 245–587), and finally SCNM 
(No. 588–681). Within each one of these UN GHS groups, 
the studies were sorted by main driver of classification. 
Within each main driver of classification, the studies were 
sorted by “physical form as tested” in the in vivo study (i.e. 
(1) liquid: “L”, (2) tested in solvent but physical state of 
neat chemical unknown: “L (tested in solvent, neat chemi-
cal unknown)”, (3) tested in solvent but neat chemical 
available as solid: “L (tested in solvent, available as S)”, 
(4) waxy/viscous solid: “S (waxy)”, (5) solid: “S”, and (6) 
unknown physical state: “unknown”). Finally, within each 
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category of “physical form as tested” the studies were 
sorted in alphabetic order of the test chemical name. The 
column “Data Source” refers to the source of the data (i.e. 
ECETOC, ZEBET, LNS, NICEATM, EURL ECVAM and 
Cosmetics Europe). The commercial source (availability 
today; provided as an example) and the available purity are 
also provided. The CAS RN, name and physical form of 
the raw chemical were verified one by one by three inde-
pendent investigators using Material Safety Data Sheets 
(MSDS), where available, or any other reliable source of 
information. This resulted in the identification of some 
transposition errors in the original in vivo data source that 
were corrected in the current database (e.g. study No. 532 
was reported with CAS RN 118-82-3 in ECETOC, while 
the correct CAS RN for this chemical, as mentioned in the 
DRD, is 118-82-1). In a few cases, the physical state of 
the raw chemical provided in the DRD could not be veri-
fied with information available today, but since a specific 
physical state was clearly indicated in the in vivo study 
report it was decided to report this in the DRD rather than 
“unknown”. The column “Number of Studies” gives infor-
mation on the number of available in vivo Draize eye test 
studies for that specific chemical: 1 of 1 refers to a single 
study, and 1 of 2 and 2 of 2 indicate that there are two inde-
pendent in vivo studies for this chemical, etc. The follow-
ing columns give detailed information on the in vivo driv-
ers of classification observed in each study, as described in 
Table 2, with the main driver of classification marked in 
boldface within a greyed cell. The column “Comments” 
contains all available detailed information on special obser-
vations such as CO = 4 (timing of appearance, reversibil-
ity, the number of animals that were affected) and persis-
tence of effects (e.g. number of animals affected and tissue 
scores). Finally, the last column in the DRD highlights 
those chemicals in the database that are not recommended 
to be used in method development and/or validation due to 
limited quality and/or reliability of the in vivo classifica-
tion, despite the fact that they may have been used in past 
validation activities (for more details see chapter “Drivers 
of classification criteria to consider when selecting refer-
ence chemicals” below.
Results and discussion
For the successful development and validation of alterna-
tive methods and strategies to fully replace the Draize rab-
bit eye test, a thorough understanding of the in vivo tissue 
effects that drive classification is of primary importance. In 
the “Results and discussion”, each chapter focuses on an 
individual element of this in-depth analysis. Detailed infor-
mation is provided and discussed from which key conclu-
sions (hereinafter referred to as evidence 1–9) are drawn in 
each chapter. The first two chapters focus on the distribu-
tion of the studies presented in the DRD (Supplementary 
Material 1) according to the UN GHS classification and the 
in vivo drivers of classification. Next, key points such as 
the variability between repeat Draize eye studies and the 
classification of chemicals as Cat 1 based only on persis-
tence of effects are discussed in detail and are illustrated 
with typical examples. Based on these in-depth analyses, 
a critical review of the UN GHS/EU CLP decision crite-
ria for classification is presented, and a revision of these 
criteria is advocated. This paper concludes with guidance 
and key criteria that should be considered when selecting 
references chemicals for the development and/or valida-
tion of alternative methods and/or for the development and 
evaluation of testing strategies. The evidence numbers pro-
vided in the various chapters below link the various obser-
vations and conclusions in the manuscript with the key 
criteria recommended for selecting reference chemicals. 
Evidence numbers were further subdivided into a, b, c, etc., 
depending on the effect being discussed, in order to pro-
vide further precision in the linking between evidence and 
recommendations.
Distribution of studies according to UN GHS 
classification
The DRD contains data on 681 Draize eye test studies 
representing 634 unique chemicals and chemical solu-
tions/suspensions in a solvent. For 94 of these 681 stud-
ies (13.8 %) UN GHS study criteria allowing an unam-
biguous classification were not met. These are identified 
as SCNM in the DRD. Among the 587 studies which met 
the UN GHS criteria for classification (representing 547 
unique chemicals and chemical solutions/suspensions in a 
solvent), 41.6 % were classified, with 13.5 % being Cat 2 
and 28.1 % being Cat 1 (Table 3). This distribution is very 
similar to that reported by Adriaens et al. (2014) for three 
reference databases that are included in the DRD (ECE-
TOC + ZEBET + LNS: 17.2 % Cat 2 and 22.6 % Cat 
1), but differs substantially from the prevalence of Cat 2 
(10.4 %) and Cat 1 (6.9 %) chemicals in the European New 
Chemicals Database (NCD) of the ex-European Chemicals 
Bureau containing data on “New Chemicals” notified under 
Directive 67/548/EEC and introduced to the EU indus-
trial market after September 1981 (Adriaens et al. 2014). 
Although the DRD contains several studies on NCD chemi-
cals for which full raw data are available, most of the stud-
ies included in the DRD have been collected over the years 
specifically to support validation activities, where the goal 
was probably to increase the proportion of Cat 2 and Cat 
1 chemicals rather than be reflective of what is observed 
in reality. The distribution of UN GHS categories observed 
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in the NCD is therefore expected to represent more closely 
the true prevalence of Cat 2 and Cat 1 chemicals.  
Distribution of studies according to in vivo drivers 
of classification
In order to better understand the relative importance of the 
different drivers of classification, each study was allocated 
to a single main driver of classification according to the 
described prioritization scheme (Table 2). The studies clas-
sified as Cat 1 (n = 165) were distributed according to six 
main drivers, two for severity in the first three observation 
days, three for persistence on day 21 and one for CO = 4. 
As can be observed in Table 3, 27.3 % of all Cat 1 stud-
ies were classified based on severity, with CO mean ≥ 3 
being the main driver of classification for the majority of 
these studies (73.3 %) (evidence 1a) and IR mean > 1.5 
being the main driver in only 26.7 % of these studies (evi-
dence 2a). About 47 % of all Cat 1 studies were classified 
based only on persistence of effects on day 21 (i.e. with CO 
mean < 3 and IR mean ≤ 1.5). For 80.5 % of these studies 
CO persistence was the main driver (evidence 1b), while 
only 19.5 % of these studies had conjunctival (CR and/or 
CC) persistence as the main driver (evidence 2b) and none 
had IR persistence as the main driver (evidence 2c). Stud-
ies classified based on CO = 4 as main driver, represented 
20.6 % of all Cat 1 studies (evidence 1c). Of note, a few 
studies (n = 9, 5.5 %) led to a Cat 1 classification based 
on other observations (e.g. pannus formation, discoloration 
of the cornea) but not on severity, persistence or CO = 4 
(evidence 3). These studies will not be further discussed in 
the current paper and therefore the total number of Cat 1 
studies considered hereafter is reduced to 156. The distri-
bution of these 156 Cat 1 studies according to their main 
drivers of classification and subgrouping according to the 
physical form of the chemicals as tested are presented in 
a cumulative bar chart in Fig. 1 (in % relative to the 156 
studies). Table 3 also shows the distribution of the physical 
form of the chemicals as tested within each main driver of 
classification (in % relative to the total number of studies 
for each individual driver). Among the 156 Cat 1 studies, 
50.6 % were performed with liquids or chemicals tested in 
solvent, 44.9 % were performed with solids and for 4.5 % 
the physical state of the test chemical is unknown (Fig. 1). 
Studies classified based on conjunctival persistence on day 
21 or studies classified based on CO = 4 as main driver 
involved more solids than liquids (including chemicals 
tested in solvent) (Fig. 1; Table 3). For the other main driv-
ers, the distribution was mostly similar to the overall distri-
bution of liquids versus solids seen for all Cat 1 chemicals 
(Fig. 1; Table 3). Among the six possible drivers that can 
result in a Cat 1 classification, CO persistence on day 21 is 
the one observed most often as main driver (evidence 1b). 
This tissue effect is responsible for classification of about 
40 % of the studies. In contrast, none of the Cat 1 studies 
was classified based on IR persistence on day 21 as main 
driver (Fig. 1) (evidence 2c). Furthermore, corneal opacity 
(including CO mean ≥ 3, CO persistence on day 21, and 
CO = 4) is the main endpoint driving Cat 1 classification, 
representing 82.7 % of all Cat 1 studies (evidence 1a, b, c). 
Table 3  Proportion (%) and number (n) of studies according to main driver of classification (chemicals requiring classification) or according to 
the subgroups (No Cat); the proportions within a framed cell add up to 100 %
UN GHS Category 1 % (n)
28.1
(165)
Category 2 % (n)
13.5
(79)













CO mean IR mean 









CO mean Conj mean IR mean 
≥ 1 ≥ 2 ≥ 1
60.8 38 1.3
(48) (30) (1)
CO > 0** CO > 0 CO = 0** CO = 0
8.7 13.1 1.7 76.4





Liquid a 54.5 66.7 53.2 40 - 72.9 60 - 73.3 53.3 66.7 65.6
(18) (8) (33) (6) (14) (35) (18) (22) (24) (4) (172)
Solid 42.4 33.3 37.1 60 - 58.8 27.1 40 100 16.7 42.2 16.7 32.1
(14) (4) (23) (9) (20) (13) (12) (5) (19) (1) (84)
Unknown 3 - 9.7 - - - - - - 10 4.4 16.7 2.3
(1) (6) (3) (2) (1) (6)
CO, corneal opacity; IR, iritis; Conj, conjunctival redness (CR) and/or conjunctival chemosis (CC)
A few chemicals (n = 9, 5.5 %: No. 157–165) (1 liquid, 6 solids and 2 physical state unknown) were classified based on “other observations” 
but not severity, or persistence or CO = 4 and are therefore omitted in the distribution of Cat 1 chemicals
** Indicates at least one animal with a mean score of days 1–3 above the classification cut-off for at least one endpoint
a  Includes solids and liquids tested in solvent
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IR mean > 1.5 (7.7 %) and conjunctival persistence on day 
21 (9.6 %) were less often observed as main drivers of clas-
sification (Fig. 1) (evidence 2a, b).
In the previous paragraph the distribution of the Cat 1 
studies was presented in terms of the main driver of classi-
fication. However, as mentioned earlier, a study can be clas-
sified based on more than one driver. The total frequency 
of each of the six individual drivers of Cat 1 classification 
was therefore also investigated (Fig. 2). The data presented 
in Fig. 2 confirm that corneal opacity is the most important 
endpoint driving the classification of Cat 1 chemicals (evi-
dence 1a, b, c). It is the effect observed most frequently, 
accounting for 72 % (232/322) of the total frequency of Cat 1 
drivers (10.6 % for CO mean ≥ 3, 28.9 % for CO pers D21 
and 32.6 % for CO = 4) (Fig. 2). In fact, as shown in the 
Supplementary Material 1, 92.9 % (145/156) of the Cat 1 
studies had sufficient corneal involvement to generate a Cat 1 
classification, with 21.8 % being classified based on CO 
mean ≥ 3, 47.4 % based on CO persistence on day 21 but 
with CO mean < 3, and 23.7 % based on CO = 4 but with 
CO mean < 3 and CO reversible by day 21 or unknown (evi-
dence 1a, b, c). The few remaining Cat 1 studies (n = 11) 
were classified based on IR mean > 1.5 only (1.9 %) (evi-
dence 2a) or conjunctival persistence only (5.1 %) (evidence 
2b). Figure 2 also demonstrates that the drivers of Cat 1 clas-
sification rarely appear on their own (i.e. in the absence of 
other Cat 1 drivers). The only exception is CO = 4, which 
was often the only observed effect driving a Cat 1 classifica-
tion, but this is mostly due to early, ethical termination of the 
study. Indeed, when CO mean ≥ 3 is the main driver of Cat 
1 classification, it is accompanied by CO = 4 in about 91 % 
(30/33) of the studies and when CO pers D21 is the main 
driver, it is accompanied by CO = 4 in 53 % (33/62) of the 
studies. CO = 4 is therefore the driver of Cat 1 classification 
that was most frequently observed (Fig. 2). Finally, Figs. 1 
and 2 show that persistence of conjunctival effects and IR on 
day 21 appeared in several studies but, while the latter was 
never observed alone and was never the main driver of clas-
sification (evidence 2c), the former was sometimes observed 
on its own and was also the main driver of classification in 
these and a few other studies (evidence 2b).
Almost 50 % of the Cat 1 studies (n = 77) were clas-

















































Fig. 1  Distribution of 156 UN GHS/EU CLP Cat 1 studies accord-
ing to their main drivers of classification and the physical state of the 
chemical as tested. The numbers in the bars correspond to the number 
of studies/the number of unique test chemicals. For selecting the main 
driver of classification in each study, highest priority was first given 
to severity (CO mean ≥ 3 and/or IR mean > 1.5 of days 1–3), fol-
lowed by persistence of effects on day 21 in the absence of severity 
(CO, Conj and/or IR pers D21), followed by CO = 4 (at any observa-
tion time during the study) in the absence of both severity and per-
sistence (or if unknown) Within the severity and persistence groups, 
the main driver corresponds to the one showing the largest number of 
animals fulfilling the classification criterion. If equal number of ani-
mals fulfilled the classification criteria for different drivers, the main 
driver was selected following the order shown on the x-axis, with pri-
ority decreasing from left to right. Note: three studies performed with 
a single animal showed CO mean ≥ 3, IR mean > 1.5, CO pers D21, 
Conj pers D21 and IR pers D21 (studies No. 50, 73 and 78), but were 
placed in the group CO pers D21 because the group CO mean ≥ 3 
can only be selected when this occurs in ≥60 % of the animals in 
studies with at least three animals. Similarly, another five studies per-
formed with a single animal showed CO mean ≥ 3 and CO = 4 (one 
also showed IR mean > 1.5), but were placed in the group CO = 4 
(studies No. 136, 138, 142, 143 and 146). Liquids *: includes solids 
and liquids tested in solvent




























































n Unknown (multiple drivers)
Solids (multiple drivers)
Solids (single driver)
Liquids * (multiple drivers)
Liquids * (single driver)
Fig. 2  Total frequency of Cat 1 drivers of classification observed in 
156 UN GHS/EU CLP Cat 1 studies. The numbers in the bars cor-
respond to the number of studies/the number of unique test chemi-
cals. The individual drivers appearing in each study were distributed 
in different groups depending if they occurred alone (single driver) or 
together with other Cat 1 drivers of classification (multiple drivers) 
and on the physical state of the chemical as tested (Liquid, Solid or 
Unknown). Note: CO mean ≥ 3 observed in eight single animal stud-
ies (No. 50, 73, 78, 136, 138, 142, 143 and 146) and IR mean > 1.5 
observed in five single animal studies (No. 50, 73, 78 and 138) are 
not counted in the chart because these effects can only be considered 
drivers of classification when they occur in ≥60 % of the animals in 
studies with at least three animals. Liquids *: includes solids and liq-
uids tested in solvent
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with CO mean < 3 and IR mean ≤ 1.5). In order to evalu-
ate the character of observed tissue damages in the initial 
phase of the study after instillation of the substance, the 
severity scores of days 1–3 in these studies were evaluated 
in more detail. Three of these studies resulted in CO mean 
≥ 3 and IR mean > 1.5, but since these were single animal 
studies, the classification was driven by persistence and not 
based on severity. For this reason, they were not considered 
in this analysis. Figure 3 shows the total frequency of each 
of the three individual drivers of Cat 2 classification and of 
absence of any drivers based on the mean scores of days 
1–3 for the remaining 74 Cat 1 studies classified based only 
on persistence of effects. CO mean ≥ 1 and Conj mean ≥ 2 
were observed with similar frequencies of 38.9 % (63/162) 
and 37.7 % (61/162), respectively, while IR mean ≥ 1 
was observed in only about half of that (20.4 %, 33/162). 
It follows that 85.1 % (63/74), 82.4 % (61/74) and 44.6 % 
(33/74) of these Cat 1 studies showed CO mean ≥ 1, Conj 
mean ≥ 2 and IR mean ≥ 1, respectively. CO mean ≥ 1 
and Conj mean ≥ 2 also occurred alone in 7 and 5 stud-
ies, respectively, while IR mean ≥ 1 always occurred 
together with CO mean ≥ 1 and/or Conj mean ≥ 2. For 
6.8 % (n = 5) of these Cat 1 studies the mean tissue scores 
of days 1–3 were below all the cut-offs that trigger classi-
fication (i.e. CO mean < 1, IR mean < 1, CR mean < 2 and 
CC mean < 2, in the majority of the animals). Two of these 
latter five Cat 1 studies (studies No. 46 and 72) showed 
delayed effects that persisted until day 21 in a minority of 
the animals. Most probably, these delayed effects were not 
directly induced by the test chemical but rather by other 
phenomena, such as microbial infection (the so-called sec-
ondary inflammatory process), differences in animal behav-
iour and/or absence of post-treatment care (Prinsen 2006, 
2014), which raises questions on the relevance of a Cat 1 
classification here. The other three (studies No. 83, 92, 
and 109) showed low-level CO effects from the beginning 
until the end of the study (day 21) in only a single animal, 
with all other animals fully reversing before day 21. Also 
here a Cat 1 classification is highly questionable. Figure 3 
shows that persistence of effects on day 21 is mainly driven 
by effects already appearing on the first 3 days. However, 
based on the mean scores of days 1–3, these Cat 1 stud-
ies cannot be distinguished from Cat 2 studies classified 
based on CO mean ≥ 1 and/or Conj mean ≥ 2. It is likely 
that methods that predict immediate severe effects but do 
not necessarily provide direct information on the persis-
tence or reversibility of effects [for example BCOP and 
ICE with their current protocols (OECD 2013a, b, respec-
tively)], will not be able to discriminate between these Cat 
1 and Cat 2 chemicals. OECD TGs 437 and 438 (OECD 
2013a, b) state that both BCOP and ICE generate a high 
number of false negatives for solids when used to identify 
chemicals inducing serious eye damage (UN GHS Cat 1). 
Looking at the validation databases of these two methods 
(ICCVAM 2007, 2010), it can indeed be confirmed that 
25 % (4/16) and 55 % (6/11) of the Cat 1 solids that were 
tested with BCOP and ICE, respectively, were underpre-
dicted. However, a closer analysis considering the in vivo 
drivers of classification described in this paper reveals that 
even higher false-negative rates were obtained with Cat 1 
chemicals classified in vivo based on persistence without 
severity: 46 % (6/13) for BCOP and 69 % (9/13) for ICE. 
It further shows that all the solids that were underpredicted 
by these two methods are classified in vivo based only on 
persistence of effects. It can therefore be concluded that the 
main limitation of these two methods [with their current 
protocols (OECD 2013a, b)] in terms of underprediction of 
Cat 1 chemicals is related to their lack of capacity to accu-
rately predict persistence of effects rather than having a 
specific limitation for solid chemicals. This simple analysis 
demonstrates the importance of looking at drivers of clas-
sification to better elucidate potential limitations of alterna-
tive methods. Although this has not been checked for other 
in vitro methods accepted or proposed to identify serious 
eye damage (e.g. FL, STE), the same outcome is expected, 
i.e. a limitation to predict in vivo persistent effects that 
occur without enough severity in the first three observation 











































































Liquids * (multiple drivers)
Liquids * (single driver)
Fig. 3  Total frequency of drivers of Cat 2 classification observed in 
74 UN GHS/EU CLP Cat 1 studies classified based on persistence of 
effects only (i.e. with CO mean < 3 and IR mean ≤ 1.5). The num-
bers in the bars correspond to the number of studies/the number of 
unique test chemicals. The individual Cat 2 drivers appearing in each 
study were distributed in different groups depending if they occurred 
alone (single driver) or together with other drivers of Cat 2 classi-
fication (multiple drivers) and on the physical state of the chemical 
as tested (Liquid, Solid or Unknown). Five of these 74 Cat 1 studies 
showed no classifiable effects in days 1–3 (no driver) and are there-
fore shown as “No Cat”. Note: three studies performed with a sin-
gle animal that showed CO mean ≥ 3, IR mean > 1.5, CO pers D21, 
Conj pers D21 and IR pers D21 (studies No. 50, 73 and 78), which 
were placed in the group CO pers D21, are not included in this figure. 
Liquids *: includes solids and liquids tested in solvent
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between reversible and irreversible effects may, however, 
be feasible using methods that were specifically developed 
for this purpose, e.g. the EVEIT (Spöler et al. 2007; Frentz 
et al. 2008) and PorCORA (Piehl et al. 2010, 2011), and/
or further development of the protocols of existing methods 
such as those currently accepted by the OECD.
The studies classified as Cat 2 (n = 79: Cat 2A being 
reversible within 21 days and Cat 2B being reversible 
within 7 days) were distributed according to three main 
drivers of classification, namely CO mean ≥ 1, Conj mean 
≥ 2 and IR mean ≥ 1. As can be observed in Table 3, 
60.8 % of all Cat 2 studies were classified based on CO 
mean ≥ 1 as the main driver of classification (evidence 4a), 
followed by 38.0 % with Conj mean ≥ 2 (evidence 4b) and 
1.3 % with IR mean ≥ 1 (evidence 2d) as the main drivers. 
Moreover, in previous analyses it was shown that CC rarely 
drives the classification of chemicals on its own (about 2 % 
of the Cat 2 chemicals) (Adriaens et al. 2014; Barroso and 
Norman 2014) and can therefore be considered unimportant 
as a driver of classification (evidence 2e). Therefore, stud-
ies with Conj mean ≥ 2 as main driver correspond almost 
always with CR mean ≥ 2 as main driver (evidence 4b). 
The distribution of Cat 2A (n = 51) and Cat 2B (n = 27) 
studies according to their main drivers of classification and 
subgrouping according to the physical form of the chemi-
cals as tested, is presented in a cumulative bar chart in 
Fig. 4 (in % relative to the total 79 studies). For one Cat 2 
study (No. 217, liquid, main driver Conj mean ≥ 2 but also 
showing CO mean ≥ 1), it is not possible to distinguish 
between Cat 2A (reversible within 21 days) and Cat 2B 
(reversible within 7 days) since no grading was recorded on 
day 7. Therefore, this study is not shown in Fig. 4. Table 3 
also shows the distribution of the physical form of the 
chemicals as tested within each main driver of classification 
(in % relative to the total number of studies for each indi-
vidual driver). A larger percentage of those studies which 
resulted in Cat 2 classifications were performed with liq-
uids or chemicals tested in solvent (67.1 %) than with sol-
ids (32.9 %) (Fig. 4). The majority of the studies was classi-
fied based on CO mean ≥ 1 as main driver (60.8 % in total: 
41.8 % Cat 2A and 19.0 % Cat 2B) (evidence 4a), followed 
by Conj mean ≥ 2 (38.0 %: 22.8 % Cat 2A and 13.9 % Cat 
2B) (evidence 4b), and only one study (1.3 %) was classi-
fied (Cat 2B) based on IR mean ≥ 1 as main driver (Fig. 4) 
(evidence 2d). The total frequency of each of the three indi-
vidual drivers of Cat 2 classification is also shown in Fig. 5. 
Corneal effects were previously shown to be very impor-
tant in driving Cat 2 classification (Adriaens et al. 2014) 
and, indeed, 69.6 % (55/79) of the Cat 2 studies (48.1 % 
(38/79) Cat 2A and 21.5 % (17/79) Cat 2B) showed CO 
mean ≥ 1 (Fig. 5). However, it is important to note that an 
even higher number of the Cat 2 studies showed sufficient 
conjunctival effects (Conj mean ≥ 2) to generate a Cat 2 
classification [83.5 % (66/79): 58.2 % (46/79) Cat 2A and 
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Fig. 4  Distribution of 51 UN GHS Cat 2A and 27 UN GHS Cat 2B 
studies according to their main drivers of classification and the physi-
cal state of the chemical as tested. The numbers in the bars corre-
spond to the number of studies/the number of unique test chemicals. 
The main driver corresponds to the one showing the largest number 
of animals fulfilling the classification criterion. If equal number of 
animals fulfilled the classification criteria for different drivers, the 
main driver was selected following the order shown on the x-axis, 
with priority decreasing from left to right. Note: one Cat 2 study is 
not included in the bar chart because a distinction between Cat 2A 
and Cat 2B is not possible due to lack of grading on day 7. Liquids *: 
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Liquids * (multiple drivers)
Liquids * (single driver)
Fig. 5  Total frequency of Cat 2 drivers of classification observed 
in 51 UN GHS Cat 2A and 27 UN GHS Cat 2B studies. The num-
bers in the bars correspond to the number of studies/the number of 
unique test chemicals. The individual drivers appearing in each study 
were distributed in different groups depending if they occurred alone 
(single driver) or together with other Cat 2 drivers of classification 
(multiple drivers) and on the physical state of the chemical as tested 
(Liquid or Solid). Note: one Cat 2 study is not included in the bar 
chart because a distinction between Cat 2A and Cat 2B is not possible 
due to lack of grading on day 7. Liquids *: includes solids and liquids 
tested in solvent
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the Cat 2 studies [6.3 % (5/79) Cat 2A and 10.1 % (8/79) 
Cat 2B] showed CO mean ≥ 1 but Conj mean < 2, almost 
double the amount [29.1 % (23/79): 16.5 % (13/79) Cat 2A 
and 12.7 % (10/79) Cat 2B] showed Conj mean ≥ 2 but 
CO mean < 1 (two of the Cat 2A and one of the Cat 2B 
studies also showed IR mean ≥ 1) (Fig. 5). It follows that, 
although CO is an important endpoint driving the clas-
sification of Cat 2 chemicals (evidence 4a), conjunctival 
effects (mainly CR) are even more important (evidence 4b). 
IR mean ≥ 1, on the other hand, never appears isolated and 
is also the least frequently observed driver of Cat 2 classifi-
cation (evidence 2d). The other two Cat 2 drivers CO mean 
≥ 1 and Conj mean ≥ 2 appear a considerable number of 
times on their own (i.e. in the absence of other Cat 2 driv-
ers) (evidence 4a, b), and more often for Cat 2B than for 
Cat 2A chemicals (Fig. 5). This is in contrast with the Cat 
1 chemicals that rarely induce a single, isolated driver of 
classification. As expected, the stronger the hazard proper-
ties of a chemical, the higher the diversity of the induced 
adverse effects.
The studies with chemicals not requiring classifica-
tion (No Cat) (n = 343) were divided into four subgroups, 
CO > 0**, CO > 0, CO = 0**, and CO = 0, as explained 
above. The majority of the No Cat studies was performed 
with liquids or chemicals tested in solvent (64.7 %). Of the 
remaining studies, 31.8 % were performed with solids and 
3.5 % with a test chemical of unknown physical state. The 
breakdown of the No Cat studies by subgroup and physical 
state is presented in Fig. 6 (in % relative to 343 studies) and 
in Table 3. Table 3 also shows the distribution of the physi-
cal form of the chemicals as tested within each subgroup 
(in % relative to the total number of studies for each sub-
group). The majority of the No Cat studies had CO = 0 in 
all animals (78.1 %) with a small percentage of these stud-
ies (1.7 %) showing a conjunctival effect above the classi-
fication cut-off in at least one animal (subgroup CO = 0**) 
(evidence 5). The remaining 21.9 % of the No Cat stud-
ies showed CO > 0, with 8.7 % of these studies showing 
a mean score of days 1–3 for at least one endpoint in at 
least one animal above the classification cut-off (subgroup 
CO > 0**) (evidence 5).
In conclusion, it is clear that effects on the cornea (93 % 
of Cat 1 studies) play a major role in driving Cat 1 classi-
fication (evidence 1a, b, c). They are also those of highest 
concern because they can lead to visual impairment. Fur-
thermore, a substantial proportion of the Cat 1 studies in 
the DRD shows CO persistence on day 21 (47.4 %, 74/156) 
but not enough CO severity in the first three observation 
days to generate a Cat 1 classification (evidence 1b). Both 
corneal opacity (71 % of Cat 2 studies) and conjunctival 
effects (84 % of Cat 2 studies) are important in driving 
Cat 2 classification, but the latter appear to hold a higher 
weight because they occur alone more often than corneal 
opacity does (29 vs. 16 %) (evidence 4a, b). Most of the 
available alternative methods were developed to predict 
first and foremost immediate corneal effects, although 
some may also correctly predict irritancy observed only in 
the conjunctiva in vivo. Nevertheless, in order to achieve 
full replacement of the Draize eye test, it will be important 
that persistence of effects is also correctly predicted with 
alternative methods.
Variability between repeat Draize eye studies
Since several chemicals in the DRD were tested more than 
once in independent studies performed by different labora-
tories, the reproducibility of the Draize eye test could be 
assessed for these chemicals. The reproducibility of the 
repeat studies was evaluated in terms of agreement of clas-
sifications and/or classification drivers and is summarised 
in Table 4 for chemicals classified as Cat 1 in at least one 
study and for chemicals for which the maximum classifica-
tion obtained in the repeat studies was Cat 2. Table 5 sum-
marises the data for chemicals not requiring classification 
in all repeat studies. Of note, studies that resulted in a Cat 
1 classification based on severity in the first three observa-
tion days or CO = 4 were sometimes terminated before 




































Fig. 6  Distribution of 343 UN GHS/EU CLP No Cat studies accord-
ing the physical state of the chemical as tested and to the following 
four subgroups: (1) CO > 0 in at least one observation time in at least 
one animal and at least one animal showing a mean score of days 1–3 
above the classification cut-off for at least one endpoint (CO > 0**), 
(2) CO > 0 in at least one observation time in at least one animal and 
all animals showing mean scores of days 1–3 below the classifica-
tion cut-offs for all endpoints (CO > 0), (3) CO = 0 in all observation 
times in all animals and at least one animal showing a mean score 
of days 1–3 above the classification cut-off for at least one endpoint 
(CO = 0**), and (4) CO = 0 in all observation times in all animals 
and all animals showing mean scores of days 1–3 below the classifi-
cation cut-offs for all endpoints (CO = 0). The numbers in the bars 
correspond to the number of studies/the number of unique test chemi-
cals. Liquids *: includes solids and liquids tested in solvent
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was available. Absence of information for this driver for a 
Cat 1 study, which is indicated by “unknown” in the DRD, 
is therefore no indication of reversibility or persistence of 
effects.
Sixteen of the chemicals with repeat studies resulted in 
a Cat 1 classification in at least one study (Table 4). The 
repeat studies were reproducible for 37.5 % (6/16) of the 
chemicals, resulting in the same UN GHS classification 
based on the same main driver of classification. For another 
four chemicals (25 %) the repeat studies also resulted in a 
Cat 1 classification but based on a different main driver of 
classification (severity versus persistence). The remaining 
six chemicals (37.5 %) resulted in a different classification 
in the repeat studies (Cat 1 vs. Cat 2). Therefore, these 16 
chemicals showed an overall concordance of classifications 
of only 62.5 % (10/16) (Table 4). Two of the six chemi-
cals with discordant classifications, namely Butoxyethanol 
and 10 % Sodium lauryl sulphate, showed persistence of 
effects without severity in the first three observation days 
in two independent studies (Butoxyethanol: studies No. 51 
and 110; 10 % Sodium lauryl sulphate: studies No. 74 and 
75), while the same effects fully reversed within 21 days in 
a third study (No. 217 and No. 189, respectively). One of 
the Cat 1 studies obtained with Butoxyethanol (study No. 
51) showed persistence of CO (CO ≤ 2) in a minority of 
the animals (1 or 2 out of 6) (evidence 6a), while the other 
(study No. 110) showed CR = 1 on day 21 in 2 of 3 ani-
mals and CC = 1 on day 21 in the third animal (evidence 
7a). For another chemical (iso-Butanol), one of the avail-
able studies (No. 589) was terminated on day 14 with a 
CO = 3 in one out of three animals while in the two other 
animals CO fully reversed by day 1 and day 14. Although 
the persistence of CO on day 21 in the first animal can-
not be confirmed, this is assumed to be the case due to the 
high CO score on day 14. This SCNM study was therefore 
assumed to be Cat 1 for the purpose of this analysis. The 
repeat study (No. 175) resulted in a Cat 2A classification 
based on CO mean ≥ 1 and Conj mean ≥ 2 in all tested ani-
mals. In three cases of inconsistent classification (includ-
ing the one described above), the Cat 1 classifications were 
driven by a single animal (No. 57, 128 and 175) (evidence 
6a). One of these studies (100 % Ethanol: study No. 57) 
resulted in CO persistence in one out of six animals, with 
the mean CO scores of days 1–3 falling between the Cat 2 
and the Cat 1 classification cut-offs, while in at least two 
other studies (No. 171 and 201) the effects fully reversed 
by day 21 in all animals resulting in a Cat 2A classifica-
tion. For another one of these three chemicals (n-Butanol), 
Table 5  Distribution of chemicals not requiring classification by subgroups: details for replicate Draize eye test studies
N corresponds with the number of repeated studies. Repeated studies are assigned with different capitals. The appearance of a capital in a given 
column indicates the subgroup of the study. Upper case letters between brackets (e.g. (B)) indicate studies for which study criteria allowing an 
unambiguous classification were not met (study criteria not met, SCNM) because the study was terminated before day 21 without full reversibil-
ity of all endpoints
** At least one animal with a mean score of days 1–3 above the classification cut-off for at least one endpoint
Chemical ID Nr N No Category SCNM Agree
CO > 0** CO > 0 CO = 0** CO = 0
Methyl amyl ketone 257, 284 2 A B Yes (≠group)
Phosphoric acid, tributyl ester 260, 446 2 A B Yes (≠group)
1,2,3-Trichloropropane 275, 327 2 A B Yes (≠group)
Methyl iso-butyl ketone 285, 286 2 AB Yes
Triethanolamine (100 %) 292, 468 2 A B Yes (≠group)
Sodium lauryl sulphate (1 %) 296, 297 2 AB Yes
Xylene 322, 483 2 A B Yes (≠group)
3-Phenoxy benzaldehyde (100 %) 358, 359 2 AB Yes
Gamma-Glycidyloxypropyltrimethoxy silane 391, 392 2 AB Yes
Gamma-Mercaptopropyl trimethoxy silane (100 %) 393, 394 2 AB Yes
Glycerol (100 %) 400, 401 2 AB Yes
Kronitex TXP 425, 426 2 AB Yes
Perfluoro-n-hexane 443, 444 2 AB Yes
Polyethylene glycol 400 (100 %) 448, 449 2 AB Yes
Tricresyl phosphate 465, 466 2 AB Yes
Tween 20 476, 477 2 AB Yes
PEG-40 hydrogenated castor oil 501, 502 2 AB Yes
Tetrabromobisphenol A 574, 677 2 A(B) B: No Cat Yes
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CO = 4 was observed in one out of three animals in the 
Cat 1 study (No. 128), whereas the repeat study (No. 179) 
resulted in a Cat 2A classification based on CO mean ≥ 1 
and Conj mean ≥ 2 in four out of four animals. Only one 
of the six chemicals with a discordant classification (Pyri-
dine) showed Cat 1 severity (CO mean ≥ 3) in one of the 
studies (No. 13) and Cat 2 severity (e.g. CO mean ≥ 1) in 
the second study (No. 184). Thus, the difference between 
repeat studies with non-concordant classification (Cat 1 vs. 
Cat 2) is mostly related to the presence of persistent and/
or CO = 4 effects in a minority of the animals (evidence 
6a), or the presence of CR and/or CC = 1 on day 21 in the 
Cat 1 studies versus the absence of such effects in the Cat 
2 studies, with no meaningful differences being observed 
in the scores of the first three observation days (evidence 
7a). These results support an earlier suggestion by Adriaens 
et al. (2014) to revise some of the current UN GHS and EU 
CLP decision criteria for the classification of chemicals 
as inducing serious eye damage (Cat 1) (see also chapter 
“Critical Review of UN GHS/EU CLP classification crite-
ria” below).
For seven of the chemicals with repeat studies, the high-
est classification obtained was Cat 2 (Table 4). Only one of 
these seven chemicals with a Cat 2 classification in at least 
one study (14.3 %), was classified consistently (Cat 2A) 
and with the same main driver of classification (CO mean 
≥ 1) across studies (No. 173 and 174). Two chemicals were 
classified consistently in two independent studies but based 
on a different driver (No. 178 and 205; No. 207 and 647). 
Two other chemicals showed the same main driver of clas-
sification in two independent studies but a difference in the 
persistence of the effects on day 7, with one study fully 
reversing by day 7 (Cat 2B) (No. 225 and 228) while the 
other did not (Cat 2A) (No. 176 and 181). Two chemicals 
resulted in a different categorisation in two independent 
studies, with one study not requiring classification (No. 317 
and 321) and another study resulting in a Cat 2A classifica-
tion based on CO mean ≥ 1 (No. 198) or a Cat 2 or higher 
classification based on Conj mean ≥ 2 (No. 627). The over-
all concordance of classifications for the chemicals hav-
ing Cat 2 as the highest classification obtained is therefore 
71.4 % (5/7) (Table 4), when considering Cat 2A and Cat 
2B as concordant classifications (as in EU where these two 
optional subcategories were not implemented). If Cat 2A 
and Cat 2B are considered as different classifications, the 
concordance decreases to 42.9 % (3/7). Finally, one chemi-
cal has two SCNM studies that were terminated before day 
21 without full reversibility of effects (No. 614 and 615). 
Both studies resulted in at least a Cat 2A classification, 
but no conclusion can be made in terms of reproducibility 
without information on the persistence/reversibility of the 
effects on day 21. Indeed, it cannot be precluded that one 
of the two studies would have shown persistent effects and 
would have been classified as Cat 1 should the study have 
been completed. These two studies were therefore not con-
sidered in the analysis of reproducibility between repeat 
Draize eye test studies presented here.
Eighteen chemicals showed a concordant No Cat outcome 
in two repeat studies (Table 5). However, the reproducibility 
of these repeat studies in terms of their subgroup was only 
72.2 % (13/18) (Table 5). Two chemicals have two repeat 
studies both belonging to the CO > 0 subgroup (studies No. 
285 and 286 and studies No. 296 and 297). For another 11 
chemicals, both repeat studies resulted in CO scores equal 
to 0 in all animals and all observed time points and none of 
the tested animals showed a mean score of days 1–3 for any 
of the endpoints above their classification cut-offs (CO = 0 
subgroup). Since these chemicals do not induce any signifi-
cant effects on the eye, observation of no effects is expected 
to be highly reproducible. Still, four other chemicals resulted 
in CO = 0 in one study (No. 446, 327, 468 and 483) and 
in CO > 0** (No. 260), CO > 0 (No. 275 and 292) or 
CO = 0** (No. 322) in another study. The studies marked 
with ** are considered borderline since they show at least 
one animal fulfilling at least one of the classification criteria, 
but not enough animals fulfilling the same criteria to actually 
generate a classification. In many of these cases, however, 
the difference between Cat 2 or No Cat lies in a single score 
in a single animal, so they do differ significantly from stud-
ies in the CO = 0 subgroup. Finally, one chemical has two 
repeat studies, one resulting in CO > 0** (study No. 257) 
and the other in CO > 0 (study No. 284). These two studies 
are, however, very similar since both show CO > 0 on at least 
one observation day in three out of four animals. Moreover, 
while one showed mean CC scores of days 1–3 of 2 (**), 
0.33, 0 and 0 (study No. 257), the other showed mean CC 
scores of days 1–3 of 1.33, 1.33, 1.33 and 1 (study No. 284), 
so the differences between the two are minimal.
Overall, for the chemicals requiring classification in at 
least one of multiple studies, the observed concordance of 
UN GHS classifications when considering a unified Cat 2 
classification is 65.2 % (15/23). If Cat 2A and Cat 2B are 
considered as different classifications, the observed con-
cordance of UN GHS classifications is 56.5 % (13/23). Con-
cordance of the same main driver of classification occurs for 
39.1 % (9/23) of the chemicals. The statistical resampling 
analysis performed by Adriaens et al. (2014), demonstrated 
an overall probability of at least 11 % that chemicals classi-
fied as Cat 1 by the Draize eye test could be equally identi-
fied as Cat 2 and of about 12 % for Cat 2 chemicals to be 
equally identified as No Cat. These proportions of misclas-
sifications reflect the within-test variability of the Draize 
eye test only. Although there are only a limited number of 
repeat studies available in the DRD, there is evidence that 
the reproducibility of the Draize eye test reduces substan-
tially when its between-laboratory reproducibility is taken 
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into account. Thus, in the current data set, 37.5 % (6/16) of 
the chemicals with at least one Cat 1 study could be equally 
identified as Cat 2 and 28.6 % (2/7) of the Cat 2 chemicals 
could be equally identified as No Cat. This confirms ear-
lier findings of Weil and Scala (1971) and Cormier et al. 
(1996). These studies already reported a high between-lab-
oratory variability of the Draize eye test method, although a 
weighted sum score of ocular lesions that gives more weight 
to corneal injury, was used in the analyses instead of the 
individual ocular tissue scores and UN GHS classification 
considered in the current analyses. It is therefore impor-
tant not to disregard the substantial variability of responses 
between Draize eye test studies and even between animals 
in the same study, as reported here and in previous studies 
(Weil and Scala 1971; Cormier et al. 1996; Prinsen 2006, 
2014; Adriaens et al. 2014), when discussing the validity, 
regulatory acceptance and use of alternative test methods 
and testing strategies for serious eye damage/eye irritation. 
Such variability can be caused by differences in animal 
behaviour, differences in exposure times, mechanical dam-
age induced by solid chemicals that are not readily washed 
off the eye, secondary inflammatory processes, absence (or 
presence) of post-treatment care and/or subjective scor-
ing (especially for those chemicals causing effects near the 
thresholds for classification) (Prinsen 2014). Moreover, if 
the variability and quality of the in vivo data are not care-
fully considered when selecting reference test chemicals for 
the validation of alternative in vitro methods, the chance of 
success of such studies may substantially decrease.
Analyses of studies classified Cat 1 based on persistence 
only
About 47 % of the Cat 1 studies were classified based on 
persistence in absence of enough CO and IR severity in 
the first three observation days (i.e. CO mean < 3 and IR 
mean ≤ 1.5). In order to better understand persistence of 
tissue effects, tissue scores were compared between (1) 
studies showing persistence of any given effect on day 21 
in the majority of the animals (i.e. in ≥60 % of the animals 
in accordance with the UN GHS/EU CLP classification cri-
teria for effects appearing during the first three observation 
days: 2 or more out of 3, 3 or more out of 4, 3 or more 
out of 5, or 4 or more out of 6) and (2) studies showing 





















































































































































































































































































































































































































































































































































































































































Fig. 7  Boxplots presenting the distribution of individual animal CO 
grades at 1, 2, 3, 7, 14 and 21 days after instillation of the test chemi-
cal for a Cat 1 studies showing CO persistence in the majority of the 
animals but with CO mean < 3 and IR mean ≤ 1.5 in the majority of 
the animals (32 studies with 116 animals), b Cat 1 studies showing 
CO persistence in the minority of the animals but with CO mean < 3 
and IR mean ≤ 1.5 in the majority of the animals (25 studies with 
104 animals), and c Cat 2A studies showing persistence of CO on day 
7 in at least one animal (28 studies with 104 animals). The symbols 
(+) present individual observations, the thick horizontal lines corre-
spond to the medians of all observations, and the whiskers correspond 
to the smallest and largest observation that fall within a distance of 
1.5 times the length of the box (Interquartile Range, IQR) from the 
lower quartile (bottom side of the box, 25th percentile) and upper 
quartile (upper side of the box, 75th percentile), respectively
▸
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of the animals (i.e. in <60 % of the animals: 1 out of 3, 
2 or less out of 4, 2 or less out of 5, or 3 or less out of 6). 
The relation between the tissue scores of these two groups 
of studies and the tissue scores observed in Cat 2A studies 
was also explored. These comparisons were performed for 
each tissue separately and single animal studies were not 
included in the analyses.
Figure 7 illustrates the distribution of CO scores as a 
function of observation time for Cat 1 studies showing CO 
persistence in the majority of the animals (boxplot A), Cat 
1 studies showing CO persistence in the minority of the 
animals (boxplot B), and Cat 2A studies with CO persis-
tence on day 7 in at least one animal (boxplot C). CO per-
sistence in the majority of the animals was observed in 32 
Cat 1 studies with 116 animals. At least 50 % of the ani-
mals in these studies showed CO scores equal to or greater 
than 2 from day 2 until day 14 (evidence 8a). The differ-
ence in distribution observed on day 21 as compared to day 
14 is mostly explained by the fact that 14 of these 32 stud-
ies were terminated before day 21, with 42 of the 45 ani-
mals included in these studies showing CO scores equal to 
or greater than 2 on day 14. In fact, 27 of these 42 animals 
actually showed a CO = 4 on day 14 and another 12 had 
CO = 3 on that last observation day. It is highly unlikely 
that such high scores would decrease by day 21, and there-
fore, if the 14 studies terminated on day 14 had been fully 
completed until day 21, the distribution of scores on day 
21 would have probably more closely resembled the distri-
bution observed on day 14 (evidence 8a). In clear contrast, 
the CO scores of the 25 Cat 1 studies with CO persistence 
in the minority of the animals decreased with time, with 
50 % of the animals already having CO scores ≤ 1 on days 
1, 2, and 3 (evidence 6b). By day 14 at least 50 % of the 
animals had CO = 0 and on day 21, CO = 0 was observed 
in 74 % (76/103) of the animals. For 19 studies (No. 55, 
57, 58, 59, 62, 65, 66, 76, 80, 83, 92, 93, 97, 102, 103, 
107, 109, 118, and 119), persistent effects on the cornea 
appeared in only 1 out of 3, 4, or 6 animals, whereas all 
other animals had low scores that reversed to 0 by day 21 
or earlier (evidence 6a). Three other studies (No. 46, 72, 
and 98) were terminated on day 14, each with a single ani-
mal showing CO > 0 on this last observation day. CO per-
sistence was assumed in all the three cases due to delayed 
CO = 4 appearing on day 3 in study No. 98 and on day 7 
in studies No. 46 and 72 (Fig. 7b), which persisted until 
day 14 on those single animals. In contrast, all other ani-
mals showed full reversibility of CO scores to 0 by day 
14 or earlier. In total, five animals in five different studies 
(No. 46, 72, 80, 98, and 107) showed delayed effects with 
a CO = 4 appearing on day 3, 7, 14, or 21 (Fig. 7b), while 
all the other animals consistently showed CO ≤ 2 (several 
times equal to 0) throughout the entire study that fully 
reversed on day 21 or earlier (Supplementary Material 
1) (evidence 6a). In general, the CO scores of the Cat 1 
chemicals classified based on CO persistence in the minor-
ity of the animals (Fig. 7b) have a similar distribution as 
those of the Cat 2A chemicals showing CO persistence 
on day 7 (Fig. 7c) (evidence 6b). In fact, based on the CO 
scores observed over the first 3 days, it is not possible to 
distinguish the Cat 1 studies with CO persistence in the 
minority of the animals (Fig. 7b) from the Cat 2A stud-
ies (Fig. 7c). CO persistence in a minority of the animals 
should therefore not be used to drive a Cat 1 classification, 
nor should isolated extreme effects (CO = 4) appearing 
late in the study, as these are most probably not related to 
the test chemical itself.
Figure 8 shows the distribution of the CR scores as 
a function of observation time for Cat 1 studies showing 
CR persistence in the majority of the animals (boxplot A), 
Cat 1 studies showing CR persistence in the minority of 
the animals (boxplot B), and Cat 2A studies with CR per-
sistence on day 7 in at least one animal (boxplot C). CR 
persistence in the majority of the animals was observed in 
16 Cat 1 studies with 55 animals. In contrast with CO, the 
CR scores of these animals appear to decrease with time 
(Figs. 7a, 8a) (evidence 8b). CR persistence in the minor-
ity of the animals was in turn observed in 20 Cat 1 studies 
with 86 animals. About 31 % (17/55) of the animals from 
Cat 1 studies with CR persistence on day 21 in the majority 
of the animals had CR ≥ 2 on day 21, while 51 % (28/55) 
had CR = 1 (Fig. 8a). In contrast, only 7 % (6/86) of the 
animals in the Cat 1 studies with CR persistence in the 
minority of the animals had CR ≥ 2 on day 21, with 20 % 
(17/86) having CR = 1 (Fig. 8b). Of note, the majority of 
the animals with CR ≥ 2 on day 21 also had CO ≥ 1 at the 
end of the study [83 %, (14 + 5)/(17 + 6)]. CR ≥ 2 on day 
21 is therefore almost always associated with some degree 
of corneal opacity (evidence 7b). The only exceptions here 
are studies No. 114 and 117. Study No. 114 resulted in 
CR = 2 (with CC = 1 and IR = 1) on day 21 in one animal, 
whereas the CO of this animal and all tissue scores of the 
two other animals reversed to 0 latest by day 15. In study 
No. 117, two out of six animals had CR = 3 on day 21 
without any additional tissue effects, but the third animal 
showed full reversibility of all tissue effects (to score 0) by 
day 21 or earlier. Study No. 84 also includes one animal 
that showed CR = 2 and CO = 0 on day 21, but the same 
study includes five other animals that showed CO persis-
tence on day 21 (scores of 1, 2, 2, 3 and 4), coupled with 
CR ≥ 2 in the four animals with highest CO scores. Stud-
ies No. 55, 62, 65, 66, 83, 93, 94, 97, 102, 112, and 113 
showed CR = 1 on day 21 in a single animal, study No. 
100 in two out of six animals, and studies No. 54 and 109 
in two out of four animals. CO persistence on day 21 was 
also observed in 14 of these 17 animals (82 %) while, for 
the other three animals, CR = 1 on day 21 was observed in 
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the absence of any other persistent effects (studies No. 109, 
112, and 113). Study No. 109 is, however, classified based 
on CO persistence on day 21 in another animal. Although 
less pronounced, CO persistence was also observed in 54 % 
(15/28) of the animals with CR = 1 on day 21 in the stud-
ies showing CR persistence in the majority of the animals. 
Based on these data, it can be concluded that studies show-
ing persistent CR on day 21 are generally also classified as 
Cat 1 based on CO persistence (evidence 7b). Furthermore, 
no important difference in the distribution of the CR scores 
can be observed between Cat 1 studies with CR persistence 
in the minority of the animals (Fig. 8b) and Cat 2A studies 
with CR persistence on day 7 (Fig. 8c) (evidence 6c). CR 
persistence in a minority of the animals should therefore 
not be used to drive a Cat 1 classification. In fact, it is not 
possible to distinguish the Cat 1 studies (Fig. 8a, b) from 
the Cat 2A studies with CR persistence on day 7 (Fig. 8c) 
based on the distribution of the CR scores from the first 
three observation days, which demonstrates that CR is not 
useful to identify Cat 1 chemicals, at least when it comes to 
effects observed in the first 3 days after instillation.
The distributions of the CC scores as a function of obser-
vation time for Cat 1 studies showing CC persistence in the 
majority of the animals (boxplot A), Cat 1 studies show-
ing CC persistence in the minority of the animals (boxplot 
B), and Cat 2A studies with CC persistence on day 7 in at 
least one animal (boxplot C) are shown in Fig. 9. Figure 9 
reveals that CC persistence on day 21 occurs less often then 
CO and CR persistence (evidence 2b). Indeed, CC persis-
tence in the majority of the animals was observed in only 
four studies (studies No. 81, 84, 105, and 120), as com-
pared to 16 and 32 studies with CR and CO persistence in 
the majority of the animals, respectively. Similar to CR, the 
CC scores of the 18 animals in the studies showing CC per-
sistence in the majority of the animals visibly decrease with 
time (Fig. 9a) (evidence 8c). This is in clear contrast with 
CO (Fig. 7a) (evidence 8a). CC persistence in the minority 
of the animals was observed in 15 studies (studies No. 59, 
66, 67, 80, 88, 93, 94, 95, 103, 107, 108, 109, 110, 114, 
and 119), as compared to 20 and 25 studies with CR and 
CO persistence in the minority of the animals, respectively. 
The percentages of animals showing CC ≥ 2 or CC = 1 
on day 21 are, however, similar to those observed for CR, 
being 28 % (5/18) and 44 % (8/18), respectively, in the Cat 
1 studies with CC persistence on day 21 in the majority of 



































































































































































































































































































































































































































































































































































































































Fig. 8  Boxplots presenting the distribution of individual animal CR 
grades at 1, 2, 3, 7, 14 and 21 days after instillation of the test chemi-
cal for a Cat 1 studies showing CR persistence in the majority of the 
animals but with CO mean < 3 and IR mean ≤ 1.5 in the majority 
of the animals (16 studies with 55 animals), b Cat 1 studies showing 
CR persistence in the minority of the animals but with CO mean < 3 
and IR mean ≤ 1.5 in the majority of the animals (20 studies with 86 
animals), and c Cat 2A studies showing persistence of CR on day 7 
in at least one animal (49 studies with 177 animals). The symbols (+) 
present individual observations, the thick horizontal lines correspond 
to the medians of all observations, and the whiskers correspond to 
the smallest and largest observation that fall within a distance of 1.5 
times the length of the box (Interquartile Range, IQR) from the lower 
quartile (bottom side of the box, 25th percentile) and upper quartile 
(upper side of the box, 75th percentile), respectively
▸
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respectively, in the Cat 1 studies with CC persistence 
on day 21 in the minority of the animals (Fig. 9b). Most 
important, the majority of the animals with CC > 0 on day 
21 also had CO ≥ 1 at the end of the study (evidence 7c). 
Indeed, 25 out of 29 animals (86 %) with CC > 0 on day 21 
also showed CO persistence at the end of the study (12 out 
of 13 and 13 out of 16 in the majority and minority groups, 
respectively) (Fig. 9a, b). The four animals with persistent 
CC but CO = 0 on day 21 (studies No. 84, 108, 110, and 
114) showed CC = 1 at the end of the study. In studies No. 
84 and 108, however, several other animals showed CO 
persistence on day 21, thus driving a Cat 1 classification 
on their own. For the other two animals from studies No. 
110 and 114, the CC = 1 on day 21 was observed in the 
absence of CO persistence in any of the animals from those 
studies. It should, however, be noted that CC fully reversed 
to 0 by day 7 in the other two animals of study No. 114 and 
by days 14 and 21 in the other two animals of study No. 
110. As with CO and CR, no important difference in the 
distribution of the CC scores can be observed between Cat 
1 studies with CC persistence in the minority of the ani-
mals (Fig. 9b) and Cat 2A studies with CC persistence on 
day 7 (Fig. 9c) (evidence 6d) and therefore, CC persistence 
in a minority of the animals should not be used to drive a 
Cat 1 classification. Also similar to CR, it is not possible to 
distinguish the Cat 1 studies (Fig. 9a, b) from the Cat 2A 
studies with CC persistence on day 7 (Fig. 9c) based on the 
distribution of the CC scores of days 1–3.
In conclusion, for Cat 1 studies classified based only on 
persistence of effects, CO persistence on day 21 is the most 
important driver of classification as it often occurs without 
CR and CC persistence (evidence 1b). CR = 0 or CC = 0 
on day 21 occur in 41 % (33/81) and 70 % (57/81) of the 
animals showing CO persistence on day 21. CR and CC 
persistence on the other hand almost always occur together 
with CO persistence on day 21 (71 % (48/68) and 86 % 
(25/29) of the animals for CR and CC, respectively) and, 
when they do not, the scores on day 21 are usually low (i.e. 
score 1) (evidence 7a, b, c). Interestingly, the presence of 
CR or CC persistence in parallel with CO persistence on 
day 21 is about 10 % higher for the Cat 1 studies show-
ing CO persistence in the minority of the animals (67 % 
of the animals for CR and 38 % for CC) than for the Cat 
1 studies showing CO persistence in the majority of the 


































































































































































































































































































































































































































































Fig. 9  Boxplots presenting the distribution of individual animal CC 
grades at 1, 2, 3, 7, 14 and 21 days after instillation of the test chemi-
cal for a Cat 1 studies showing CC persistence in the majority of the 
animals but with CO mean < 3 and IR mean ≤ 1.5 in the majority 
of the animals (4 studies with 18 animals), b Cat 1 studies showing 
CC persistence in the minority of the animals but with CO mean < 3 
and IR mean ≤ 1.5 in the majority of the animals (15 studies with 62 
animals), and c Cat 2A studies showing persistence of CC on day 7 
in at least one animal (34 studies with 129 animals). The symbols (+) 
present individual observations, the thick horizontal lines correspond 
to the medians of all observations, and the whiskers correspond to 
the smallest and largest observation that fall within a distance of 1.5 
times the length of the box (Interquartile Range, IQR) from the lower 
quartile (bottom side of the box, 25th percentile) and upper quartile 
(upper side of the box, 75th percentile), respectively
▸
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This supports the view that in many of the studies show-
ing effects on the minority of the animals, these are not 
directly induced by the test chemical but rather by other 
phenomena like differences in animal behaviour, mechani-
cal damage, and/or a secondary inflammatory process 
(Prinsen 2014), which are expected to affect all tissues 
more indiscriminately. Overall, there were only two out 
of 14 studies (14 %) where a CR ≥ 2 on day 21 in one 
animal did not occur together with CO persistence in that 
or any other animal (studies No. 114 and 117) (evidence 
7b). This was never observed for CC (evidence 7c). Fur-
thermore, a gradual decrease in CR and CC scores can be 
observed as a function of time (Figs. 8, 9) (evidence 6c, d 
and 8b, c), which does not occur with CO scores obtained 
in Cat 1 studies with CO persistence in the majority of the 
animals (Fig. 7a) (evidence 8a). This indicates that con-
junctival effects are generally reversible by nature and thus 
suggests that they are not important and should not be used 
for driving Cat 1 classifications, especially when the score 
on day 21 is equal to 1 (evidence 7a). Accordingly, the US 
EPA classification system considers CR and CC scores of 
less than 2 as fully cleared (US EPA 1998, 2011; ICCVAM 
2010). Moreover, conjunctival scores higher than 1 on day 
21 are almost always accompanied by CO persistence on 
day 21 and are therefore unimportant from a classification 
perspective (evidence 7b, c).
Critical review of UN GHS/EU CLP classification 
criteria
According to the UN GHS classification criteria, a Cat 
1 classification can be triggered based on tissue effects 
observed in a single animal only. For example, some 
chemicals considered as Cat 1 are not classified based on 
severity (days 1–3) but based on one animal with low-
level persistent effects or a single animal showing delayed 
effects, whereas all other animals have low scores that 
reverse to 0 by day 21 or earlier. Some examples of this 
situation were already mentioned above which, unsurpris-
ingly, were linked to variability of responses and classifica-
tions between repeat studies (evidence 6a). Other examples 
like this but for which only a single study is available are 
1,4-dimethylbenzene (No. 46) and 1-naphthalene acetic 
acid (No. 80). Both were tested in six animals and resulted 
in a delayed effect in one single animal (CO = 4 appear-
ing on day 7 and day 14, respectively), whereas all tissue 
scores reversed to 0 by day 21 or earlier in all other ani-
mals. If the single animal with persistent effects for 1-naph-
thalene acetic acid was not taken into account, this chemi-
cal would be classified as Cat 2A. The Cat 1 classification 
of 1,4-dimethylbenzene is even more questionable since 
this chemical would not require classification (subgroup 
CO > 0**) if the one animal showing a delayed effect was 
not taken into account. Four other studies included in the 
DRD (No. 72, 83, 92 and 109) show a similar profile to 
1,4-dimethylbenzene, i.e. they are classified as Cat 1 due 
to CO persistence in a single animal but do not fulfil any of 
the classification criteria (for Cat 1 or Cat 2) on the basis of 
the tissue scores recorded in the first three observation days 
(evidence 6a). Clear examples of studies where the major-
ity of the animals showed full reversibility of effects by day 
21 or earlier and one animal (or the minority of animals) 
showed persistence of low-level CO appearing throughout 
the study or persistence of delayed high level CO effects 
appearing beyond day 3 are studies No. 46, 51, 55, 57, 58, 
59, 62, 65, 66, 67, 71, 72, 76, 80, 83, 92, 93, 97, 98, 102, 
103, 107, 109, 118 and 119. Detailed information on indi-
vidual tissue scores is provided in column “Comments” of 
the DRD (Supplementary Material 1). It is questionable 
whether this type of effects should lead to a Cat 1 classifi-
cation, especially the cases of delayed effects observed in 
a single animal as these occur probably for reasons unre-
lated to the test chemical, such as mechanical abrasion due 
to prolonged exposure, microbial infection (the so-called 
secondary inflammatory process), and/or differences in ani-
mal behaviour (Prinsen 2006, 2014) (evidence 6a). Many 
of these studies were probably conducted before the 2002 
update of OECD TG 405 (OECD 2012a), when rinsing of 
the eye was not allowed before the 24-h reading (changed 
to 1 h for solids in 2002). This may have led to a large vari-
ation of contact time between the test chemical and the eye 
from a couple of minutes to 24 h in different animals and 
may have thus led in some cases to an exacerbated expo-
sure that could explain the discordant effects observed in 
a single animal (or the minority of the animals). To add 
to this, animals are immediately released into their home 
cages after treatment, where they can move freely. While 
some animals may immediately start grooming and/or 
scratching and do this excessively, others may not react 
at all. These variations in behaviour are another important 
source of variability between animals (Prinsen 2006, 2014).
A Cat 1 classification based only on persistence of low-
level conjunctival effects (score 1) in the absence of any 
other Cat 1-triggering effects is also highly questionable. 
As already mentioned above, the US EPA classification 
system considers CR and CC scores of less than 2 as fully 
cleared (US EPA 1998, 2011; ICCVAM 2010). Adriaens 
et al. (2014) demonstrated that a significant proportion of 
the No Cat studies show mean CR scores over days 1–3 
equal to or greater than 1. The information provided in the 
DRD (Supplementary Material 1) further demonstrates that 
a Conj mean ≥ 2 over days 1–3 in at least one animal can 
even occur in studies that do not lead to classification of 
the test chemical. This happens in 23 of the 343 No Cat 
studies (6.7 %) included in the DRD (Supplementary Mate-
rial 1), none of which requires classification because such 
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effects were not observed in the majority of the animals 
(subgroups CO >0** and CO = 0**). Indeed, conjunctival 
effects can only trigger a Cat 2 classification in case a CR 
mean ≥ 2 and/or a CC mean ≥ 2 is observed in the major-
ity of the animals and therefore it seems logical to consider 
CR and CC scores less than 2 as “fully reversed” (evidence 
7a). Of the 45 Cat 1 studies in the DRD (Supplementary 
Material 1) that show CR and/or CC > 0 on day 21 in at 
least one animal but have CO mean < 3 and IR mean ≤ 1.5 
(in days 1–3), 27 (60 %) show maximum CR and CC = 1 
on day 21 (studies No. 50, 52, 54, 55, 62, 65, 66, 67, 82, 
83, 90, 93, 94, 95, 97, 100, 102, 108, 109, 110, 112, 113, 
115, 116, 118, 121, and 122) and 18 (40 %) show CR and/
or CC > 1 on day 21 in at least one animal (studies No. 53, 
59, 61, 73, 78, 80, 81, 84, 85, 88, 103, 105, 107, 111, 114, 
117, 119, and 120). Sixteen of 23 studies (69.6 %) with 
maximum CR and CC = 1 on day 21 (studies No. 54, 55, 
62, 65, 66, 67, 83, 93, 94, 95, 97, 100, 102, 109, 112, and 
113) and 6 of 15 studies (40 %) with CR and/or CC > 1 
on day 21 in at least one animal (studies No. 59, 61, 80, 
103, 107, and 114) show CR and/or CC > 0 on day 21 in 
a single animal or in a minority of the animals. For seven 
studies no conclusion could be made regarding minority 
versus majority of animals because persistence data are 
only available for one animal. More important, seven of 
the 45 Cat 1 studies mentioned above (No. 110, 112, 113, 
115, 117, 121, and 122) are classified based only on per-
sistence of conjunctival effects. Of these, 85.7 % (n = 6) 
show maximum CR and CC = 1 on day 21 (all but study 
No. 117) and in two studies (No. 112–10 % Triton X-100 
and No. 113–10 % Igepon AC-78) a CR = 1 on day 21 was 
observed in only one out of six animals. From these data 
it can be concluded that: (1) in the majority of the stud-
ies where conjunctival effects do not reverse to 0 by day 
21, the CR and/or CC scores obtained on day 21 are equal 
to or less than 1, and (2) in more than half of the studies 
where conjunctival effects do not reverse to 0 by day 21, 
these “persistent” effects are observed in only a single ani-
mal or in a minority of the animals. Conjunctival scores of 
1 on day 21 have nevertheless an important weight in driv-
ing the Cat 1 classification of chemicals according to cur-
rent UN GHS/EU CLP classification criteria. We question 
whether this is scientifically justifiable. The biological rel-
evance of persistence of conjunctival effects in driving Cat 
1 classification in the absence of any other Cat 1 triggering 
effects was already questioned by Adriaens et al. (2014). 
The analyses presented here provide further evidence in 
support of a recommendation to revise UN GHS and EU 
CLP classification criteria for classification of chemicals as 
Cat 1 based on persistence of conjunctival effects on day 
21. It is strongly recommended that chemicals should not 
be classified as Cat 1 based on CR and/or CC scores of 1 on 
day 21, in the absence of any other Cat 1-triggering effects 
(evidence 7a).
The DRD (Supplementary Material 1) also contains sev-
eral studies with animals for which a CO = 4 was noted that 
reversed to 0 by day 21 or earlier. These studies are marked 
in green in the column “Comments” in the DRD (Sup-
plementary Material 1). In the current dataset, a CO = 4 
scored anytime during the observation period was noted for 
261 animals out of a total of 406 used in those studies. This 
represents only 64 % of the tested animals, which indicates 
that when CO = 4 is observed in one animal it is not con-
sistently observed in the other animals used in the same 
study. Moreover, corneal opacity scores equal to 4 reversed 
to 0 by day 21 or earlier in 4.6 % (12/261) of the animals (2 
animals in studies No. 2, 27, and 155; 1 animal in studies 
No. 11, 63, 125, 126, 136, and 144) and persisted (CO > 0) 
until day 21 in 25.7 % (67/261) of the animals. The major-
ity of the animals having CO = 4 (69.7 %, 182/261) were 
killed before day 21 with CO > 0 due to animal welfare 
concerns, but 28 % (73/261) were killed on day 14 with 
CO = 4 and 4.6 % (12/261) with CO = 3 also on day 14. 
For all of these, it is quite probable that CO would have 
persisted until day 21 but for the other 37.2 % (97/261) 
it remains unknown whether full recovery could have 
occurred. According to the US EPA classification system, 
test chemicals showing CO = 4 that reverses to 0 by day 21 
or earlier are not classified as US EPA cat 1 if CO and IR 
revert to 0 and CR and CC revert to less than 2 by day 21 
in all tested animals (US EPA 1998, 2011; ICCVAM 2010). 
The UN GHS/EU CLP Cat 1 classification is also driven 
by the occurrence of “irreversible effects on the eye”, being 
defined as “the production of tissue damage in the eye,… 
which is not fully reversible within 21 days of appli-cat-
ion” (UN 2103; EC 2008). Conversely, Cat 2 is associ-
ated with “reversible effects on the eye”, being defined as 
“the production of changes in the eye …, which are fully 
reversible within 21 days of application”. UN GHS and 
EU CLP also state that “grade 4 cornea lesions and other 
severe reactions… observed at any time during the test…” 
are considered as serious eye damage and should be clas-
sified as Cat 1. These criteria were defined to permit the 
ethical early termination of studies where such extreme CO 
scores are observed because these effects are generally not 
expected to reverse within 21 days. A question arises, how-
ever, when these studies are followed through to the end 
and the observed grade 4 CO actually reverses to 0 within 
21 days. Studies in the DRD (Supplementary Material 1) 
with CO = 4 recorded any time during the observation 
period for one or more animals in the absence of any other 
Cat 1-triggering effects and showing or expected to show 
(if terminated before day 21) full reversibility of all end-
points by day 21 at latest are studies No. 125 (Methoxy-
ethyl acrylate), 126 (Methyl thioglycolate), 144 (Acid blue 
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40), and 155 (Thiourea). Considering the high subjectivity 
of the scoring of ocular lesions in the in vivo Draize eye 
test (Prinsen 2014) and the fact that no other Cat 1-trigger-
ing effects (severity or persistence) were observed in these 
studies, it is questionable if these chemicals should be clas-
sified Cat 1. In fact, the Cat 2 classification criteria are ful-
filled in all these cases, including full reversibility within 
21 days. It is therefore proposed that a Cat 2 classification 
would be more appropriate (evidence 9).
The data presented and discussed in this paper fur-
ther support the various recommendations made earlier 
by Adriaens et al. (2014) on critical revisions of the UN 
GHS and EU CLP decision criteria for the classification 
of chemicals based on the in vivo Draize eye test. On the 
basis of the evidence provided in this paper, implementa-
tion of the following recommendations should thus be 
considered: (1) CR and CC scores of less than 2 on day 
21 should be recognised as fully reversed and should 
therefore not drive a Cat 1 classification in the absence 
of any other Cat 1 triggering effects; (2) the classifica-
tion of chemicals as Cat 1 based on persistence of effects 
(i.e. CO > 0, IR > 0, CR > 1 or CC > 1 on day 21) or 
CO = 4 observed anytime during the study should follow 
a majority rule as currently done for effects observed in 
days 1–3 (severity), i.e. in at least 2 out of 3, 3 out of 4, 
3 out of 5, or 4 out of 6 animals—in particular, low-level 
persistent effects or persistence occurring due to delayed 
effects, which are observed in a single animal are probably 
not related to the test chemical and should therefore not 
drive a Cat 1 classification in the absence of any other Cat 
1 triggering effects in the study and (3) grade 4 CO scores 
that fully reverse within 21 days should not trigger a Cat 
1 classification in the absence of any other Cat 1 trigger-
ing effects. Importantly, until such time as these proposed 
revisions are implemented, chemicals that are considered 
as Cat 1 on the basis of the effects described above should 
not be included in validation studies of alternative meth-
ods. Such chemicals could lead to a decision of non-valid-
ity of an alternative method when validation criteria such 
as the absence of under classified Cat 1 chemicals is used 
which, in our opinion, would not be scientifically justifi-
able. Therefore, the establishment of validity criteria and 
chemicals selection should be carefully considered before 
initiating a validation study.
Drivers of classification criteria to consider 
when selecting reference chemicals
On the basis of the in-depth analyses provided in this paper, 
a number of key criteria have been identified that should be 
taken into consideration when selecting reference chemi-
cals for the development, evaluation and/or validation of 
alternative methods and/or strategies for serious eye dam-
age/eye irritation testing. These are:
•	 The expected applicability of the alternative method in 
terms of UN GHS/EU CLP hazard category prediction 
needs to be established. Depending on this applicabil-
ity, different alternative methods will predict different 
classification scenarios within the UN GHS/EU CLP 
classification systems, which are: (1) discriminating all 
individual categories, i.e. “Cat 1 vs. Cat 2 vs. No Cat”, 
(2) “No Cat vs. [Classified (Cat 2/Cat 1)]” and (3) “Cat 
1 vs. (Cat 2/No Cat)”.
•	 Important drivers of classification for each UN GHS/EU 
CLP category need to be represented in the chemicals 
selection. These are:
•	 For Cat 1: CO mean ≥ 3 (days 1–3) in ≥60 % of the 
animals; CO persistence on day 21 in ≥60 % of the 
animals (with CO mean < 3); CO = 4 in ≥60 % of 
the animals in the absence of persistence and with 
CO mean < 3 (or if unknown) (conclusion supported 
by evidence 1a, b, c and 8a, b, c).
•	 For Cat 2: CO mean ≥ 1 and CR mean ≥ 2 (includ-
ing some chemicals where each of these two drivers 
appears in the absence of the other one) (conclusion 
supported by evidence 4a, b).
•	 No Cat: CO = 0 and CO > 0, i.e. clear negative 
results in which no or minor effects are observed; a 
few CO = 0** and CO > 0**, i.e. borderline in vivo 
results (conclusion supported by evidence 5). Some 
chemicals with borderline in vivo results should be 
tested during method development in order to avoid 
the development of highly overpredictive meth-
ods and should also be tested in validation studies 
to properly assess the specificity of the alternative 
methods.
The distribution of the drivers of classification may dif-
fer depending on the purpose of the alternative method. 
The inclusion of IR and CC as drivers of classification 
in the chemicals selection is not important since they 
rarely drive the classification of chemicals in vivo (con-
clusion supported by evidence 2a, b, c, d, e).
•	 Chemicals classified in vivo (Draize eye test) as Cat 1 
based only on CO = 4 and/or persistent effects appear-
ing in a minority (<60 %) of the animals, should not be 
used in either prospective studies or retrospective evalu-
ations (conclusion supported by evidence 6a, b, c, d).
•	 Chemicals classified in vivo (Draize eye test) as Cat 1 
on the basis of single animal studies should not be used 
in prospective studies due to the high level of uncer-
tainty associated with the classifications derived from 
such studies (conclusion supported by evidence 6a). 
Caution should be applied for their use in retrospective 
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evaluations for which the physico-chemical parameters 
should also be taken into consideration.
•	 Chemicals classified in vivo (Draize eye test) as Cat 1 
based only on persistence of CR and/or CC equal to 1 
on day 21 should not be used in either prospective stud-
ies or retrospective evaluations (conclusion supported 
by evidence 7a). Furthermore, inclusion of CR and/or 
CC persistence ≥2 on day 21 as drivers of classifica-
tion is not important, since when this occurs it is mostly 
accompanied by CO persistence on day 21 (conclusions 
supported by evidence 7b, c).
•	 Chemicals classified in vivo (Draize eye test) as Cat 1 
based on CO = 4 that reversed to 0 before day 21, even 
if CO = 4 was observed in the majority of the animals, 
should not be used in either prospective studies or retro-
spective evaluations (conclusion supported by evidence 
9).
•	 Only those chemicals that have full observed data from 
which a definitive classification can be derived should 
be selected. Chemicals that have in vivo data that are 
SCNM should not be routinely used in prospective 
studies, unless other studies for the same chemical are 
available in the DRD having a clear classification that 
appears to be consistent with what was observed in the 
SCNM study. Chemicals with only a SCNM study but 
for which a classification can be assumed with some 
level of certainty, i.e. those that are identified in the 
DRD as “SCNM (Cat 1)”, “SCNM (Cat 2A)”, “SCNM 
(Cat 2)”, “SCNM (Cat 2B)”, or “SCNM (No Cat)”, 
should still not be used in prospective studies because 
better options with a clear classification are available in 
the DRD. Chemicals that are identified in the DRD as 
“SCNM (Cat 1)”, “SCNM (Cat 2A or higher)”, “SCNM 
(Cat 2 or Cat 1)”, “SCNM (Cat 2A)”, “SCNM (Cat 2)”, 
or “SCNM (Cat 2B)” may however be used in retro-
spective evaluations of alternative methods for the clas-
sification scenario “No Cat versus Classified (Cat 2/Cat 
1)” since the available in vivo data allows the conclu-
sion that all of these chemicals require classification 
(the uncertainty lies only on the correct classification). 
Such chemicals should nevertheless not be used for the 
development/evaluation of testing strategies, where the 
aim is to fully replace the in vivo Draize eye test.
•	 Chemicals that are classified Cat 1 based on specific 
observations in the absence of any other Cat 1 trigger-
ing effect should in general not be selected for prospec-
tive testing in validation studies as this accounts for a 
very limited number of studies in the DRD and better 
reference chemicals are available for selection (conclu-
sion supported by evidence 3). An exception could be 
the testing of strong colourants in order to demonstrate 
the capacity of an alternative method to correctly clas-
sify chemicals classified in vivo due to discoloration of 
the cornea (e.g. studies No. 159 and 160 in the DRD).
•	 Chemicals for which repeat in vivo studies are identified 
in the DRD should have the following considerations 
taken into account:
•	 Repeat in vivo studies with discordant classifica-
tions should not be used in either prospective stud-
ies or retrospective evaluations. Chemicals with 
repeat studies identifying Cat 2A and Cat 2B clas-
sifications (e.g. Methyl acetate with studies No. 
176 and 225, and n-Octanol with studies No. 181 
and 228) may still be used when these two optional 
categories are not implemented and a unified Cat 2 
classification is used (e.g. under the EU CLP clas-
sification system).
•	 The selection of chemicals with repeat in vivo stud-
ies with concordant classifications but based on dif-
ferent main drivers depends on the purpose of the 
alternative method.
•	 For No Cat chemicals in which studies showing 
in vivo responses CO > 0** and CO = 0 (e.g. phos-
phoric acid, tributyl ester; studies No. 260 and 446) 
should not be used in either prospective studies or 
retrospective evaluations as this is considered a large 
variation in the in vivo responses that could lead to 
an apparent over-classification by alternative meth-
ods.
•	 Chemicals that were tested at different concentrations 
and where the highest classification was obtained with 
the lowest concentration should only be selected with 
caution and depending on the test chemical in question 
(it’s chemical class and functional use) and the in vitro 
test method under evaluation.
•	 It is important to take into account the physical form 
(liquids, solids, waxy/viscous) of the chemicals as 
tested and balance the selection appropriately, where 
possible. For chemicals that are tested in solvent, the 
choice of vehicle is important as is the identification of 
the physical form of the neat chemical and of the chemi-
cal as tested, e.g. solution, suspension, emulsion.
•	 The purity of the chemicals should be as high as pos-
sible and ideally ≥95 %.
•	 Chemicals should be relevant in terms of their repre-
sentative functional and chemical classes and indus-
trial use. This may involve choosing chemicals cover-
ing wide ranging or selected organic functional groups 
(determined using, e.g. the OECD QSAR Toolbox, 
as provided in column “Organic Functional Groups” 
of the DRD), and covering wide ranging or selected 
functionality/industrial use (e.g. industrial chemicals/
intermediates, pesticides, pharmaceuticals, food addi-
tives.).
545Arch Toxicol (2017) 91:521–547 
1 3
Based on the criteria described above, chemicals that 
should not be selected for the development, evaluation 
and/or prospective validation of alternative methods and/
or testing strategies for serious eye damage/eye irritation 
are marked with an “X” in the DRD in the column enti-
tled “Should Not Be Used” (Supplementary Material 1). 
Some chemicals that may be selected in certain circum-
stances are marked with “(X)”. This is the case for strong 
colourants (studies No. 159, 160 and 162), for chemicals 
that were tested in a single animal but that showed severe 
and persistent effects classifiable as Cat 1 (studies No. 50, 
73 and 78) and for chemicals with repeat studies identi-
fying Cat 2A and Cat 2B classifications (studies No. 176, 
181, 225 and 228). Finally, chemicals that could in prin-
ciple be chosen in future studies but that are proprietary 
or have unknown commercial source are marked with a 
“?”. All remaining chemicals that are not marked in the 
column entitled “Should Not Be Used” are considered to 
be good reference chemicals. Considering the chemicals in 
the DRD that are commercially available today (511 indi-
vidual chemicals tested in 556 studies), only about 73 % 
(375 individual chemicals tested in 402 studies) are con-
sidered good reference chemicals that can be selected for 
future studies. About 1 % (6 individual chemicals tested 
in 8 studies) are not generally recommended for selection 
but may be used depending on the purpose of the study. 
That leaves about 25 % (130 individual chemicals tested 
in 146 studies) that are not recommended for selection. 
This is quite a large number considering that all of these 
chemicals were used in past validation studies of alterna-
tive methods and many may also have been used in their 
development. Regrettably, this may have led to sub-opti-
mal development of the methods or, more importantly, to 
the methods being considered not scientifically valid in 
validation studies.
In conclusion, the DRD provided in Supplementary 
Material 1 is an invaluable tool for selecting reference 
chemicals with an appropriate coverage of the relevant 
in vivo drivers of classification for use in the development, 
evaluation and/or validation of alternative methods and 
testing strategies to assess the serious eye damage/eye irri-
tation potential of chemicals.
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